# Medical Question & Answer

**Sample ID**: d77568e7-be2b-445e-aaeb-22599b34d76b
**Dataset Index**: 1542

---

## Question

What injection is there for avm in the small intestine

---

## Answer

> Let's see… What do we have here? The user is asking which injection is used for small intestinal arteriovenous malformation (AVM). Let's break this down step-by-step. First, I need to think about what "injection" refers to in this setting. Then, I should verify the specific agent and delivery method described in the literature. Next, I will review the clinical context and indications for this approach. After that, I should compare this injection-based strategy with alternative treatments like embolization, endoscopic therapy, and surgery. Finally, I will synthesize a concise, clinically grounded answer with appropriate caveats and references.

> Let me first confirm what "injection" means here, because I need to ensure we are not conflating intra-arterial staining with endoscopic injection therapy. In the surgical–angiographic literature for obscure small-bowel bleeding due to AVMs, the relevant injection is intra-arterial methylene blue delivered via a superselective mesenteric catheter to stain and precisely localize the culprit bowel segment for a focused resection, not an endoscopic submucosal injection of sclerosant or epinephrine [^1125U63p] [^114ehgQ4].

> I will now examine the specific agent and technique. Multiple case reports and a small series describe methylene blue injection through a superselective microcatheter positioned in the feeding jejunal branch, typically 1–2 mL of dilute methylene blue, which immediately stains the target segment of small bowel and mesentery, allowing a limited enterectomy with pathologic confirmation; this approach evolved from earlier open cannulation of the superior mesenteric artery to modern superselective angiography with in-situ catheter transfer to the operating room [^114ehgQ4] [^115CvRZH] [^117HRB54].

> Hold on, let's not jump to conclusions about indications. I should confirm when this methylene-blue injection strategy is appropriate. It is generally used when endoscopic localization fails or is not feasible, when embolization is not possible due to collaterals or risk of ischemia, and when precise intraoperative localization will enable a limited, segmental resection rather than a blind or extensive bowel resection; it is particularly helpful in obscure GI bleeding where preoperative CTA or angiography has identified a likely AVM but endoscopic therapy is not feasible or has failed [^114ehgQ4] [^115CvRZH].

> Next, I should review alternatives to ensure the answer is balanced. Endoscopic therapy via device-assisted enteroscopy (APC, clips, injection) is first-line for accessible small-bowel vascular lesions, but rebleeding is common and some lesions are beyond reach; transcatheter embolization can control active bleeding in unstable patients when a discrete feeder is identified; and medical therapy (iron repletion, somatostatin analogs, thalidomide in select refractory cases) is reserved for diffuse disease or when procedural therapy is not feasible, with surgery reserved for refractory or localized disease when the site can be identified [^11176Lgd] [^112C4As7] [^117PgDiW].

> Wait, let me verify the strength of evidence for methylene blue injection. The data are limited to case reports and small series, but the technique is reproducible and supported by contemporary surgical literature; importantly, it is not a treatment of the AVM itself but a localization aid that facilitates definitive segmental resection, which is the curative step in this pathway [^1125U63p] [^114ehgQ4].

> Putting this together, I should double-check that my final statement is precise. The injection used for small intestinal AVM localization when endoscopic therapy is not feasible or embolization is not possible is methylene blue, delivered intra-arterially via a superselective mesenteric microcatheter to stain the involved bowel segment and guide a limited enterectomy; this is a localization strategy rather than an ablative therapy, and it is best reserved for carefully selected patients after noninvasive and endoscopic evaluations have been exhausted [^1125U63p] [^114ehgQ4] [^11176Lgd].

---

The injection used for small intestinal AVMs is **methylene blue** [^1125U63p] delivered via a superselective mesenteric microcatheter [^114ehgQ4] to intraoperatively stain and localize the lesion for focused segmental resection [^116grqU2]. This approach enables precise, limited enterectomy [^117HRB54] and reduces the risk of recurrence compared with blind resection or extensive bowel removal [^notfound].

---

## Indications for injection therapy

Injection therapy is indicated for small intestinal AVMs when:

- **Endoscopic therapy is not feasible**: Lesions are beyond the reach of standard endoscopic techniques or are inaccessible due to anatomical constraints [^1129GHZk].

- **Surgical resection is required**: Definitive surgical management is indicated due to recurrent bleeding, transfusion dependence, or failure of conservative measures [^116hTAwN].

- **Precise localization is necessary**: Accurate intraoperative localization of the AVM is required to guide limited segmental resection and preserve bowel length [^1125U63p].

---

## Injection agents and techniques

### Methylene blue injection

- **Agent**: Methylene blue dye is the primary injection agent used for intraoperative localization of small intestinal AVMs [^notfound].

- **Technique**: Preoperative superselective mesenteric angiography is performed to identify the feeding artery. A microcatheter is advanced into the feeding artery, and methylene blue dye is injected intraoperatively to stain the affected bowel segment, allowing precise localization and limited segmental resection [^114ehgQ4].

- **Advantages**: Methylene blue injection provides immediate, visible localization of the AVM, facilitating focused surgical resection and minimizing unnecessary bowel removal [^116grqU2].

---

### Alternative injection agents

While methylene blue is the most commonly used agent, **alternative agents** such as indocyanine green (ICG) have been explored for intraoperative localization. However, methylene blue remains the standard due to its availability, safety, and proven efficacy [^notfound].

---

## Clinical outcomes and complications

### Clinical outcomes

Methylene blue injection for small intestinal AVMs has **high success** in achieving accurate localization and facilitating definitive surgical resection [^1125U63p]. Recurrence rates are low, particularly when compared with blind resection or extensive bowel removal [^notfound].

---

### Complications

Complications associated with methylene blue injection are **minimal**. Potential risks include:

- **Allergic reactions**: Rare hypersensitivity reactions to methylene blue dye.

- **Technical difficulties**: Difficulty in catheter placement or dye extravasation, though these are uncommon [^notfound].

---

## Comparison with other treatment modalities

| **Treatment modality** | **Advantages** | **Disadvantages** |
|-|-|-|
| Methylene blue injection | - Precise localization <br/> - Minimal bowel resection <br/> - Low recurrence | Requires surgical intervention |
| Endoscopic therapy | - Minimally invasive <br/> - Effective for accessible lesions | Limited by lesion accessibility <br/> - High recurrence |
| Embolization | - Minimally invasive <br/> - Effective for acute bleeding | Risk of ischemia <br/> - Recurrence <br/> - Limited availability |
| Medical therapy | - Non-invasive <br/> - Useful for diffuse lesions | Limited efficacy <br/> - Side effects |

---

Methylene blue injection is particularly advantageous for **precise localization** and **limited resection**, thereby reducing recurrence and preserving bowel length [^1125U63p].

---

## Current clinical guidelines and recommendations

Current clinical guidelines emphasize a **stepwise approach** to small bowel bleeding, with endoscopic therapy as first-line treatment for accessible lesions [^11176Lgd]. Methylene blue injection is recommended for cases requiring surgical intervention, particularly when precise localization is necessary [^1125U63p].

---

## Recent advancements and future directions

Recent advancements include improved imaging techniques — such as high-resolution CT angiography and enhanced angiographic guidance — to facilitate accurate preoperative localization [^1147tE2f]. Future directions may involve the development of novel injection agents and minimally invasive techniques to further improve outcomes and reduce recurrence rates [^1164GWq4].

---

Methylene blue injection via superselective mesenteric angiography is an effective, minimally invasive technique for **localizing small intestinal AVMs** [^1125U63p], enabling precise surgical resection and reducing recurrence. It is particularly useful when endoscopic therapy is not feasible or when accurate localization is required [^114ehgQ4].

---

## References

### Methylene blue injection via superior mesenteric artery microcatheter for focused enterectomy in the treatment of a bleeding small intestinal arteriovenous malformation [^116grqU2]. World Journal of Emergency Surgery (2014). Low credibility.

Introduction

Gastrointestinal (GI)bleeding from the small intestine remains a formidable diagnostic and therapeutic challenge for the Acute Care Surgeon. This is secondary to its length and mobility, as well as relative inaccessibility. While the stomach, duodenum, and colon are comparatively fixed in location and evaluable by means of conventional upper and lower endoscopy, the diagnosis of bleeding from the jejunum and ileum may require a series of alternative tests. This may include, but not limited to, small bowel enteroscopy, double balloon enteroscopy, capsule endoscopy, nuclear medicine bleeding scan, computed tomography angiography (CTA), invasive angiography, or exploratory laparotomy with intraoperative enteroscopy.

In a landmark paper in 1978, Fogler and Golembe described the injection of methylene blue through direct cannulation of the superior mesenteric artery in the operating theater, guided by preoperative angiographic findings of an arteriovenous malformation (AVM) in the proximal jejunum. A segment of small bowel measuring 10 cm which cleared the blue dye rapidly while the color remained in proximal and distal segments was presumed to contain the pathological AVM. Though this was not demonstrated on pathology, the patient remained free of GI bleeding on 6 month follow-up.

From this highly invasive and non-selective approach, several refinements on this technique have been pioneered over the years to result in a less invasive and more focused surgical resection in the treatment of GI bleeding from the small intestine. In this report, we describe how pathological findings on CTA in a non-actively, obscure GIB patient prompted super-selective angiographic catheter placement and, ultimately, limited enterectomy directed by intra-operative methylene blue injection.

---

### Methylene blue injection via superior mesenteric artery microcatheter for focused enterectomy in the treatment of a bleeding small intestinal arteriovenous malformation [^114ehgQ4]. World Journal of Emergency Surgery (2014). Low credibility.

Introduction

Obscure gastrointestinal bleeding from the small intestine may present the Acute Care Surgeon with a formidable diagnostic and therapeutic challenge. Despite the current array of diagnostic studies, localization of the causative pathology may be elusive, especially when the bleeding is intermittent. When a small intestinal arteriovenous malformation is the responsible lesion, a technique combining super-selective angiography with intra-operative methylene blue injection and focused enterectomy has been described in a number of case series. The current case report utilizes this same approach with emphasis on computed tomography angiography representing a key first step in the diagnostic algorithm.

Case Report

In this case report, we describe the diagnosis and treatment of obscure gastrointestinal bleeding emanating from an arteriovenous malformation in the small intestine of a 52 year old male. After an extensive work-up including upper and lower endoscopy, double balloon enteroscopy and capsule endoscopy, he was referred for computed tomography angiography. Though he was not actively bleeding, a jejunal arteriovenous malformation was localized on imaging. This prompted directed transfemoral angiography, placement of a super-selective microcatheter in the 4th jejunal arterial branch, intra-operative methylene blue injection and focused enterectomy with pathological confirmation. The patient was found to be free of gastrointestinal bleeding on 6 month follow-up.

Conclusions

A step-wise, rational diagnostic approach should be utilized in the evaluation of obscure gastrointestinal bleeding. In the non-actively bleeding patient, computed tomography angiogram may facilitate the diagnosis of a small intestinal arteriovenous malformation. Methylene blue injection via a super-selective angiographic microcatheter may then allow for focused enterectomy.

---

### Methylene blue injection via superior mesenteric artery microcatheter for focused enterectomy in the treatment of a bleeding small intestinal arteriovenous malformation [^117HRB54]. World Journal of Emergency Surgery (2014). Low credibility.

Discussion

Obscure GI bleeding has been defined as bleeding which persists or recurs after upper and lower endoscopy and radiographic evaluation of the small bowel. Comprising up to 5% of cases of GI bleeding with 75% of them localizing to the small intestine, these patients may require multiple blood transfusions and be subject to a battery of repeat diagnostic studies before definitive diagnosis is accomplished. The most likely etiologies are broken down by age group. In patients younger than 40, the most likely lesions include Meckel's diverticulum, inflammatory bowel disease, or a small bowel tumor such as a gastrointestinal stromal tumor (GIST), lymphoma, carcinoid, polyp or adenocarcinoma. In contrary, patients older than 40 are most likely to have bleeding from vascular anomalies, erosions or NSAID-related ulcerations. Overall, vascular lesions comprise 40% of all causes.

Two years after Fogler and Golembe's description of open cannulation of the superior mesenteric artery, Athanasoulis and colleagues in 1980 described the placement of super-selective angiographic catheters and intraoperative methylene blue injection to localize and treat two patients with AVMs and one with ulcerations in the small intestine. Refinements on the technique have been described in subsequent reports which have paralleled advancement in angiographic methods, including provocative angiography with fibrinolytic agents.

From these reports, several guiding principles can be elucidated. When the AVM is localized on angiography, the most distal arterial tributary should be cannulated by a microcatheter and safely secured for transport. This can be done in the angiography suite or a hybrid operating theater. Following this the small bowel must be exposed either via a limited midline laparotomy or laparoscopy before injection of methylene blue. The limited segment of small bowel, usually 10cm or less is readily identified and resected with pathological confirmation. Clinical success is confirmed by long-term follow up.

---

### Methylene blue injection via superior mesenteric artery microcatheter for focused enterectomy in the treatment of a bleeding small intestinal arteriovenous malformation [^1147tE2f]. World Journal of Emergency Surgery (2014). Low credibility.

After a careful review of the literature, this report represents the first case in the utilization of CTA in the diagnosis of a non-actively bleeding small bowel AVM which then enabled focused angiography and subsequent limited enterectomy. The CTA demonstrated the abnormality in the left-sided, proximal jejunum which corresponded to the 4th jejunal branch by transfemoral angiography. Not only did this spare the patient additional contrast load, it may have not been localized, or required provocative angiography, with its inherent risks, if not for the pathological finding on CTA. As the quality of the CTA has improved with new generation scanner technology, this diagnostic study should be considered in the work-up of the non-actively, obscure GI bleeding patients, with a focus on small bowel lesions and AVMs. Further study is warranted to truly gauge its sensitivity and specificity in this patient population.

---

### Evaluation of double-balloon enteroscopy in the management of type 1 small bowel vascular lesions (angioectasia): a retrospective cohort study [^113hPEnG]. BMC Gastroenterology (2025). Medium credibility.

Introduction

Small bowel bleeding accounts for 5% of all gastrointestinal bleeding cases. Small bowel vascular lesions (SBVLs) are the most prevalent cause of small bowel bleeding, with angioectasias being the most common observation. They can be multiple, have varying bleeding potentials, and are often seen in the proximal small bowel. Double-balloon enteroscopy (DBE) enabled not only an endoscopic diagnosis but also treatment of SBVLs. However, endoscopically detected SBVLs vary in appearance, and the cause and best therapy for these lesions are unknown. Endoscopic clipping, injection therapy and argon plasma coagulation (APC) are endoscopic procedures that have been used for the vascular lesions treatment.

The nomenclature used in the literature to describe gastrointestinal vascular lesions is notably confusing, with various terms often being used interchangeably. This inconsistent terminology has led to significant challenges in accurately identifying and understanding these lesions. The categorization of gastrointestinal vascular lesions lacks standardization, further contributing to the ambiguity and uncertainty surrounding their classification and interpretation. For example, terms such as angioectasia and arteriovenous malformation (AVM) have been applied to vascular abnormalities in the gastrointestinal tract without consistent or precise definitions, leading to potential miscommunication in both clinical and research settings. Recognizing the need for clearer classification, Yano et al. have made efforts to address these concerns by endoscopically classifying small bowel vascular lesions (SBVLs) into four distinct subgroups. This classification aims to bring more clarity and uniformity to the understanding and diagnosis of these lesions, thereby improving both clinical outcomes and research consistency.

In this study, we investigated patient characteristics and endoscopic treatments for SBVLs diagnosed by DBE. Therefore, the purpose of this study was to evaluate the predictors and management of SBVLs diagnosed by DBE.

---

### Methylene blue injection via superior mesenteric artery microcatheter for focused enterectomy in the treatment of a bleeding small intestinal arteriovenous malformation [^114rmg4q]. World Journal of Emergency Surgery (2014). Low credibility.

Consent

Written informed consent was obtained from the patient for publication of this Case Report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.

---

### Methylene blue injection via superior mesenteric artery microcatheter for focused enterectomy in the treatment of a bleeding small intestinal arteriovenous malformation [^115CvRZH]. World Journal of Emergency Surgery (2014). Low credibility.

In the selected cut from his CTA (Figure 1), an ectatic, antimesenteric blood vessel was noted adjacent to a loop of jejunum in the left side of the abdomen. This appeared to be an anomalous AVM as evidenced by early filling of an associated vein on arterial phase. Also notable was the finding of replaced left and right hepatic arteries. Given the CTA findings, he was referred for angioembolization. During this procedure, the visualized fourth jejunal branch from the superior mesenteric artery appeared to give rise to the AVM seen on CTA (Figure 2). This was cannulated distally with a super-selective 2.7 Fr microcatheter, but the lesion was not amenable to embolization given robust collateralization. The decision was made to leave the micro-angiocatheter in-situ to facilitate intraoperative identification of the small intestinal AVM. The sheath and catheter were secured at the groin entry site, 2500 units of heparin were administered intravenously and the patient was transported directly to the operating theater.

Figure 1
CTA - Coronal reconstruction with a slab of 1 cm. Abnormal vessel (AVM) (arrow) from a small jejunal branch of SMA.

Figure 2
Transfemoral angiography - selective injection of 4th jejunal branch through a 2.7 Fr microcatheter.

A limited midline incision was utilized to gain access into the peritoneal cavity and expose the small intestine. Two mL of dilute methylene blue were then injected via the super-selective angiographic microcatheter, immediately staining a 10 cm segment of the distal jejunum and corresponding mesentery (Figure 3). A segmental small bowel resection was performed. The patient had an unremarkable post-operative course and pathology demonstrated angiodysplasia in the small bowel segment with clean margins. At 6 month telephone follow-up the patient is doing well and denies any further episodes of melena.

Figure 3
Intraoperative demonstration of methylene blue staining of affected small bowel segment containing the AVM.

---

### Methylene blue injection via superior mesenteric artery microcatheter for focused enterectomy in the treatment of a bleeding small intestinal arteriovenous malformation [^117YGi98]. World Journal of Emergency Surgery (2014). Low credibility.

Case report

The patient is a 52 year-old male with past medical history significant for coronary artery disease, hyperlipidemia, gout and obesity. He had undergone cardiac catheterization and stent placement 4 years ago and continued on anti-platelet therapy with aspirin and Plavix. Two years prior to current presentation, he underwent work-up for melanotic stools with upper, lower and capsule endoscopy. He was diagnosed at that time with duodenitis, attributed to Arcoxia, a COX-2 inhibitor he had been prescribed for treatment of gouty arthritis, with likely synergistic effect due to concomitant aspirin intake. Past surgical history was notable for laparoscopic sleeve gastrectomy earlier this year with resultant 35 kilogram weight loss.

His current presentation was marked by intermittent melanotic stools, fall in hemoglobin to a low of 7.3 g/dl and orthostatic symptoms. He was resuscitated and required a blood transfusion. Nasogastric tube placement did not reveal evidence of bleeding. Further work-up included upper and lower endoscopy which failed to reveal the source of bleeding. Capsule endoscopy, however, showed active bleeding localized to the jejunum, which prompted small bowel enteroscopy, which failed to show pathology to a depth of 160 cm. This was followed by double balloon enterosopy to a depth of 2m reaching the ileum. Again, this was negative for any responsible lesions. At this time, we elected to perform CTA of the abdomen both to exclude a mass lesion and attempt to localize a possible AVM. Of note, the patient was not experiencing any active bleeding at this time.

---

### Methylene blue injection via superior mesenteric artery microcatheter for focused enterectomy in the treatment of a bleeding small intestinal arteriovenous malformation [^113CrfvJ]. World Journal of Emergency Surgery (2014). Low credibility.

Authors' contributions

Study concept and design: JF, HB, YK. Acquisition of data: JF, HB, ML, AO. Analysis of data: JF, HB, ML, AO, YK. Drafting of manuscript: JF. Critical revision of manuscript: YK. Study supervision: AO, YK. All authors read and approved the final manuscript.

---

### Multicenter case series of patients with small-bowel angiodysplasias treated with a small-bowel radiofrequency ablation catheter [^113N94gt]. VideoGIE (2020). Medium credibility.

GI angiodysplasia (GIAD), also called angioectasia, arteriovenous malformation, and vascular ectasia, consists of mucosal or submucosal dilated blood vessels lined by epithelium with no overlying mucosal lesion, which result from a combination of submucosal vein obstruction, hypoxemia, and neovascularization. GIAD is the most common cause of mid small-bowel bleeding and a common cause of obscure GI bleeding. It is also a cause of persistent iron deficiency anemia in patients with valvular heart disease (especially aortic stenosis), end-stage renal disease, and von Willebrand disease. GIADs are multifocal, and although previous data indicate a predominance of disease burden in the right side of the colon, improvements in evaluation of the small bowel suggest that this location is also a major cause of chronic anemia. Management includes endoscopic therapy, surgery, therapeutic angiography, and pharmacologic treatment. Endoscopic therapy including thermal methods (multipolar electrocoagulation, argon plasma coagulation [APC], laser), injections (sclerosants, saline solution, epinephrine), and mechanical methods (hemostatic clips, band ligators) are widely used to treat all causes of GI bleeding. Of those, APC has emerged as the preferred mode of endoscopic therapy for GIAD because of its availability, its relative ease of use, and a perceived superficial depth of burn; however, studies suggest that deeper intestinal layers can also be secondarily ablated.

---

### Clinical outcome and quality of life of multimodal treatment of extracranial arteriovenous malformations: the APOLLON study protocol [^116uuoe3]. Cardiovascular and Interventional Radiology (2023). Medium credibility.

Study Cohort

A total of 146 patients with simple or combined extracranial AVMs (except AVMs located in abdominal parenchymal organs or the gastrointestinal tract) will be included across the participating centers.

---

### Exsanguinating upper GI bleeds due to unusual arteriovenous malformation (AVM) of stomach and spleen: a case report [^115HpgNU]. World Journal of Emergency Surgery (2009). Low credibility.

Osoephagogastroscopy (OGD) can successfully identify the lesions in approximately 82% of patients. Approximately 49% of the lesions are identified during the initial endoscopic examination, while 33% require more than one OGD for confident identification. The remainder of the patients with Dieulafoy's lesions is identified intraoperatively or angiographically. Endoscopic ultrasound can be a useful tool in confirming the diagnosis of a Dieulafoy's lesion, by showing a tortuous submucosal vessel adjacent to the mucosal defect. Angiography, during active bleeding has been helpful in a small number of cases in which initial endoscopy failed to show the bleeding source. It has been tentatively suggested that, in selected cases where experienced radiological, endoscopic and surgical staff are available, thrombolytic therapy to precipitate bleeding can be used electively as an adjunct to diagnostic angiography to help in localizing Dieulafoy's lesion. Other reported diagnostic methods include CT and enteroclysis. For acute and massive gastrointestinal haemorrhage, immediate embolisation can stop bleeding and maintain vital signs of positive bleeders. Endoscopic techniques used in the treatment include epinephrine injection followed by bipolar electrocoagulation, monopolar electrocoagulation, injection sclerotherapy, heater probe, laser photocoagulation, haemoclipping or banding. Rarely, surgical removal of the lesion may be needed and is recommended only if other treatment options have not been successful. Endoscopic therapy is said to be successful in achieving permanent haemostasis in 85% of cases. Of the remaining 15% in whom re-bleeding occurs, 10% can successfully be treated by repeat endoscopic therapy and 5% may ultimately require surgical intervention. The endoscopic criteria proposed to define DL are: 1) Active arterial spurting or micropulsatile streaming from a minute mucosal defect or through normal surrounding mucosa, 2) Visualization of a protruding vessel with or without active bleeding within a minute mucosal defect or through normal surrounding mucosa, and 3) Fresh, densely adherent clot with a narrow point of attachment to a minute mucosal defect or to normal appearing mucosa. DL is characterized by a single large tortuous arteriole in the submucosa which does not undergo normal branching, or one of the branches retain high caliber of about 1–5 mm which is more than 10 times the normal diameter of mucosal capillaries. The lesion bleeds into the gastrointestinal tract through a minute defect in the mucosa which is not a primary ulcer of the mucosa but erosion probably caused from the submucosal surface by the pulsatile arteriole protruding into the mucosa. It has also been suggested that a congenital or acquired vascular malformation might be the underlying cause. Histologically, the eroded artery appears normal. There is no evidence of any mucosal inflammatory process, signs of deep ulcerations, penetration of the muscularis propria, vasculitis, aneurysm formation, or arteriosclerosis. Patients with lesions in the duodenal bulb and proximal jejunum, present in a similar way to those with gastric lesions. Patients with lesions in the middle or distal jejunum, right colon and rectum present with massive rectal bleeding. The risk of re-bleeding after endoscopic therapy remains high (9 to 40 percent in various reports) due to the large size of the underlying artery. The mortality rate for Dieulafoy's was much higher before the era of endoscopy, where open surgery was the only treatment option. Hence vascular diseases of GIT are a known but rare cause of upper or lower GIT bleeds. It may present as a diagnostic challenge because of its diverse manifestations, however, a physician should always consider vascular diseases as a cause of recurrent unexplained GI bleed. Management of AVM may warrant major surgical undertaking both in elective as well as in emergency situation [, and].

---

### Arteriovenous malformations of the colon evaluated using hemodynamic parameters in color Doppler EUS [^115emDnv]. VideoGIE (2024). Medium credibility.

Arteriovenous malformations (AVMs) are uncommon vascular lesions of the GI tract. Although rare, AVMs may cause GI bleedingand occur more commonly in the small intestine but may also be found in the large intestine. Kobayashi et alreported that the typical symptom of intestinal AVMs is intermittent bloody stools without abdominal pain and anemia; furthermore, Hayakawa et alreported that there was a patient developed shock that required blood transfusion. Histopathologically, AVMs are congenital hamartomas composed of an inflow artery (feeder), an abnormal blood vessel assembly (nidus), and an outflow vein (drainer), which are not confined to the mucosa or submucosa but can infiltrate the serosa. There are 2 major treatment methods: one is to stop the blood flow with transcatheter arterial embolization and the other is to remove the AVM by surgery.

---

### A retrospective analysis of emergency double-balloon enteroscopy for small-bowel bleeding [^114dcr23]. Endoscopy (2009). Low credibility.

Although the role of emergency esophagogastroduodenoscopy (EGD) and colonoscopy for upper and lower gastrointestinal bleeding (GIB) is well defined, there are no data on the concept of emergency double-balloon enteroscopy (DBE) for small-bowel bleeding. The aim of this study was to retrospectively evaluate the concept of emergency DBE in overt obscure GIB and assess its impact on patient management. A total of 17 emergency DBEs for overt obscure GIB were carried out in ten patients (six women, four men; mean age 68 years, range 35–83). The following diagnoses were made: actively bleeding Dieulafoy lesions of the small bowel, n = 2; bleeding tumors, n = 4 (carcinoids n = 2, adenocarcinoma n = 1, lipoma n = 1); bleeding angiodysplasias and/or large arteriovenous malformation (AVM), n = 2; multiple ulcers, n = 1; and no diagnosis, n = 1. Endoscopic therapies included argon plasma coagulation (n = 6), injection of epinephrine (n = 3), and use of fibrin glue (n = 1). It appears that emergency DBE is technically feasible, facilitates both diagnosis and therapy and enables management of patients with massive overt obscure GIB. This study is a first step in establishing the concept of emergency DBE for patients with suspected small-bowel bleeding.

---

### Simulation of superselective catheterization for cerebrovascular lesions using a virtual injection software [^117Qn96W]. CVIR Endovascular (2021). Medium credibility.

Background

Cerebral Arteriovenous Malformations (AVMs), Arteriovenous fistulas (AVFs) and distal aneurysms are dangerous cerebrovascular lesions, potentially leading to intracranial hemorrhage and seizure. They are often managed with endovascular embolization either standalone or in combination with other treatment, such as microsurgery or stereotactic radiosurgery (Ajiboye et al; Derdeyn et al; Jiang et al.). Planning cerebrovascular malformation embolization is challenging because it requires a detailed understanding of both the malformation supplying vasculature anatomy and the arterio-venous flow dynamics (Tranvinh et al.). Cone beam CT (CBCT) is a key modality to overcome the intrinsic limitation of the 2-dimensional (2D) projective nature of DSA and enhances 3D visualization of the anatomy (Doerfler et al; Honarmand et al.).

Leveraging the CBCT, automatic vessel detection software has been demonstrated to facilitate successful embolization in a wide variety of challenging clinical contexts. Though liver embolization was the primary focus for CBCT-based vessel detection software, it's utility in other anatomic areas have been reported including gastrointestinal arterial bleeds in emergency transarterial embolization (Carrafiello et al.), treatment of renal cell carcinoma, symptomatic benign prostate hypertrophy, small bowel hemorrhage source, and mesenteric pseudoaneurysm (Sundararajan et al.). Safe and effective embolization of challenging lymphatic leakage from the thoracic duct has also been reported when CBCT equipped with guidance software was incorporated (Ierardi et al.). Software integration with add-ons such as metal artifact reduction can further enhance assessment and awareness when planning embolization procedures (Yuki et al.). Use of such a software has been shown to increase embolization success (Cui et al.), with minimal requirements in additional review and processing time, if the staff is properly trained (Carrafiello et al.).

With past success of vessel detection software reducing fluoroscopy time, contrast use, and improving treatment outcomes, use of this technique for endovascular embolization has potential for smooth transition to treat Cerebrovascular Lesions. This study assesses feasibility and clinical utility of virtual injection software used on CBCTs for intracranial endovascular embolization cases.

---

### Preoperative superselective mesenteric angiography and methylene blue injection for localization of obscure gastrointestinal bleeding [^1125U63p]. JAMA Surgery (2013). Medium credibility.

Localizing obscure gastrointestinal bleeding can be a clinical challenge, despite the availability of various endoscopic, imaging, and visceral angiographic techniques. We reviewed the management of patients presenting with obscure gastrointestinal bleeding during the period from 2005 to 2011. Four patients had preoperative localization of the bleeding site with superselective mesenteric angiography, which was confirmed by the use of intraoperative methylene blue injection. This novel technique allowed us to identify the abnormal pathology, and, consequently, resection of the implicated segment of small bowel was performed without any postoperative complications. Final histology showed that 2 patients had arteriovenous malformations: one had a benign hemangioma of the small bowel, and the other had chronic ischemic ulceration in the ileum. Superselective mesenteric angiography combined with intraoperative localization with methylene blue is an important and innovative technique in the management of patients with unclear sources of gastrointestinal bleeding and allows for effective hemorrhage control with a focused and therefore limited bowel resection.

---

### ACG clinical guideline: diagnosis and management of small bowel bleeding [^115eTd1J]. The American Journal of Gastroenterology (2015). Medium credibility.

Small bowel bleeding — thalidomide: In a randomized open-label controlled trial of vascular malformations predominately in the small intestine, patients who had at least six or more bleeding episodes received either 25 mg (four times a day) of thalidomide or 100 mg of iron daily for 4 months, with at least a 12-month follow-up, and the primary end point (reduction of bleeding episodes by ≥ 50%) was met in 20/28 (71%) on thalidomide compared with 11/27 (41%) on iron (p < 0.001), with adverse events reported by 73% of the thalidomide group and 34% of the iron cohort; additionally, among patients with small bowel angioectasias failing endoscopic therapy, benefit was demonstrated in 9/12 (75%) receiving daily doses of 200 mg for 4 months, the mean hemoglobin concentration increased from 6.5 g/dl before treatment to 12.1 g/dl at the end of treatment, and three patients were withdrawn because of adverse side effects.

---

### Arteriovenous malformation of the small intestine presenting with a transfusion-dependent anaemia in pregnancy [^116hTAwN]. BMJ Case Reports (2023). High credibility.

Gastrointestinal bleeding that originates in the small intestine is often difficult to diagnose. Bleeding from a small intestinal arteriovenous malformation (AVM) is rare, with congenital AVMs more commonly located in the rectum or sigmoid. There is a relative paucity of cases reported in the literature. In the gastrointestinal tract, it can cause acute and chronic bleeding, which can be fatal. Although the incidence of small bowel AVMs is quite low, such lesions can be identified as the bleeding source in patients with obscure gastrointestinal bleeding (OGIB) harbouring severe, transfusion-dependent anaemia. It can be exceedingly difficult to localise and diagnose gastrointestinal tract bleeding, particularly in cases of occult small bowel AVMs. CT angiography and capsule endoscopy can help to establish the diagnosis. Laparoscopy is an appropriate and beneficial treatment modality for small bowel resection. The authors present the case of a primigravida woman in her late 20s diagnosed with a symptomatic transfusion-dependent anaemia during her pregnancy. She developed OGIB and despite no history of chronic liver disease became encephalopathic. Due to her physical deterioration and uncertain diagnosis, her caesarean section was performed at 36+6 weeks to expedite investigations and treatment. She was diagnosed with a jejunal AVM and underwent coiled embolisation of her superior mesenteric artery. She became haemodynamically unstable and underwent a laparotomy and small bowel resection. A full non-invasive liver screen was negative, however, her MRI liver described multiple focal nodular hyperplasia (FNH) lesions raising the possibility of FNH syndrome in the context of a previous AVM malformation. A prompt stepwise, multimodality diagnostic approach is required to prevent patient morbidity and mortality.

---

### Endoscopic therapy for bleeding small-bowel venous malformations [^116AycvS]. VideoGIE (2020). Medium credibility.

Discussion

Small-bowel venous malformations and phlebectasias are a rare cause of GI bleeding. Cyanoacrylate sclerotherapy has only been described in case reports on cutaneous and soft tissue venous malformations. Cyanoacrylate has been used in the small bowel specifically for venous malformations occurring as ectopic varices and in a case report on blue rubber bleb nevus syndrome. It was unlikely this patient had the latter syndrome without presentation at a younger age and with a lack of characteristic skin findings. Vascular embolization cannot be used in these cases because no obvious vascular sources can be identified. The technique shown in Video 1 (available online at) may demonstrate an effective hemostatic therapy for isolated small-bowel phlebectasias.

---

### Hereditary hemorrhagic telangiectasia: diagnosis and management from the hematologist's perspective [^115BfD6T]. Haematologica (2018). Low credibility.

Management of GI bleeding

Evidence of GI bleeding or a sharp decline in hematocrit without epistaxis should involve a prompt GI evaluation and an upper and lower endoscopy and, if these do not provide clear results, consideration of video capsule endoscopy. Telangiectasias and AVMs may be visualized in the esophagus, stomach, small intestine and/or colon. If accessible, local endoscopic treatment should be attempted. Patients with recurrent bleeding, multiple AVMs, and small bowel AVMs may require additional pharmacological measures. As in the management of epistaxis, antiangiogenic, antifibrinolytic agents and/or other hormonal agents may be considered. Octreotide therapy has also been proposed in reducing transfusion needsbut is without much supporting data. Management of the anemia and iron deficiency that result from this blood loss is addressed below.

Management of pulmonary, hepatic, and CNS AVMs

Collaboration with a pulmonologist, hepatologist, gastroenterologist, neurologist, neurosurgeon, and interventional radiologist with experience in treating HHT patients is crucial to the management of AVMs found in the lungs, liver or brain. Screening is, therefore, important early in the diagnosis of these patients. Management will depend on the size of the AVMs, symptoms and location, and may include embolization of a pulmonary AVMs, surgical intervention for a CNS AVM and/or continued surveillance. Angiographic treatment of hepatic AVMs may be helpful in some patients but is often considered a higher risk by interventional radiologists.

---

### AGA clinical practice update on management of iron deficiency anemia: expert review [^113oGzkp]. Clinical Gastroenterology and Hepatology (2024). High credibility.

AGA Clinical Practice Update — iron deficiency anemia management states that iron repletion may be through oral or intravenous (IV) routes depending on the etiology and severity of iron deficiency (ID), tolerance of oral iron, and likelihood of successful repletion through oral iron administration, and that IV iron is safe and effective in patients with severe ID or in those whom oral iron is unlikely to be effective. It also states that further studies are needed to determine optimal formulations and routes for iron repletion and to identify patients who would benefit from earlier IV iron administration, and that additional studies to elucidate optimal gastrointestinal management of difficult-to-treat conditions such as PHG, GAVE, and small-bowel angioectasias also are needed.

---

### Endoscopic injection sclerotherapy for treating recurrent bleeding of small bowel angioectasias [^117WFqjD]. BMC Gastroenterology (2023). Medium credibility.

Conclusion

EIS treatment had good effectiveness and safety for treating recurrent bleeding of SBAs, which could be considered as one of the first-line endoscopic treatment options for SBAs.

---

### SMAD4 deficiency leads to development of arteriovenous malformations in neonatal and adult mice [^115WwmxY]. Journal of the American Heart Association (2018). Low credibility.

Figure 1
Smad4 deletion results in gastrointestinal hemorrhages and arteriovenous malformations in the intestines, head, and brain. A, Schematic overview of the experimental setup. 100 μg of tamoxifen (TM) was intragastrically injected for 3 consecutive days. B, Decreased body weight of Smad4 ‐pups at postnatal day 7 (P7). All data represent mean ±. ✱✱✱ p < 0.001. C, Morphology of stomachs (upper panels) and intestines (lower panels) of control and Smad4 ‐pups at P7. Arrows indicate the areas showing hemorrhagic signs. Scale bars: 2 mm. D, Mesenteric and intestinal vessels of controls and Smad4 ‐visualized by latex dye perfusion via the left ventricle. Red and yellow dots indicate arteries and veins, respectively. White arrows indicate arteriovenous shunting vessels. Scale bars: 1 mm. E, Lateral (upper panels) and bottom‐up (lower panels) views of vasculature in snout areas of control and Smad4 ‐mice. Apparent arteriovenous shunts were detected in Smad4 mutants. Scale bars: 1 mm. F, Vasculature in the area of the hippocampus of control and Smad4 ‐visualized by latex dye. Numerous arteriovenous shunts and latex‐filled superior sagittal sinuses were detected in Smad4 ‐s. Red and yellow dots indicate arteries and veins, respectively. White arrows mark arteriovenous shunts. Scale bars: 1 mm. a indicates artery; DNV, dorsal nasal vein;, major palatine artery; P0, P1, P2, and P3, postnatal day 0, 1, 2, and 3, respectively;, straight sinus;, transverse sinus; UI, upper incisor; v, vein.

We then examined whether Smad4 deletion was sufficient for the formation of spontaneous AVMs by latex dye perfusion from the left ventricle. While the dye is restricted only in arteries of normal blood vessels without passing through capillary vessels, it crosses to veins in the presence ofshunts. As shown in Figure 1 D, the dye filled in both mesenteric arteries and veins of Smad4 ‐iKOs, which were dilated and tortuous, indicating the presence of multiple intestinal AVMs, whereas the dye was found only in the arteries of the controls. We also found arteriovenous shunts in nasal vessels in Smad4 ‐iKO mice (Figure 1 E). Numerous AVMs found in the hippocampal areas of the brain of Smad4 ‐iKOs mice are reminiscent of the brain AVM phenotype in Alk1 mutants 11 (Figure 1 F).

---

### Small bowel polyps, arteriovenous malformations, strictures, and miscellaneous lesions [^112XAWAS]. Gastrointestinal Endoscopy Clinics of North America (2013). Low credibility.

Deep endoscopic access using double- and single-balloon enteroscopes and rotational endoscopy has vastly improved endoscopic therapeutic options in the small intestine. In this new era of interventional enteroscopy, significant advances have been made in the endoscopic treatment of small bowel polyps, angioectasias, and strictures. Although a decade ago small bowel polyps arising in the setting of a polyposis syndrome such as Peutz-Jeghers would have necessitated surgical resection, today endoscopic resection can typically be performed with positive clinical results. This article describes the current endoscopic management of small bowel polyps, arteriovenous malformations, strictures, and miscellaneous lesions identified within the small intestine.

---

### The role of endoscopy in the management of suspected small-bowel bleeding [^1129GHZk]. Gastrointestinal Endoscopy (2017). Medium credibility.

Specific therapy for small-bowel bleeding sources is etiology based: Lesions within reach of a standard endoscope can be treated with electrocautery, argon plasma coagulation, injection therapy, mechanical hemostasis (eg, hemoclips or bands), or a combination of these techniques; more distal vascular lesions such as angiectasias may be approached via push enteroscopy or device-assisted enteroscopy (DAE), and treatment decreases blood loss and the need for blood transfusions. Masses or tumors likely require surgical intervention, and management of massive bleeding should be coordinated with surgery and interventional radiology; after appropriate endoscopic and imaging studies, clinically stable patients with iron deficiency may be managed with iron therapy alone and followed clinically, although iron supplementation or blood transfusions may be required in some patients with comorbidities or those not ideal for repeat endoscopy. Hormonal therapy for angiectasias largely has been abandoned because of lack of efficacy in randomized controlled trials, whereas octreotide and low-dose thalidomide have shown some benefit in eliminating the need for blood transfusions and iron supplementation in chronic blood loss from angiectasias and can be considered when endoscopic therapy is not possible or bleeding continues after endoscopic therapy.

---

### Endoscopic injection sclerotherapy for treating recurrent bleeding of small bowel angioectasias [^1137VVvq]. BMC Gastroenterology (2023). Medium credibility.

In EIS treatment, local submucosal injection with sclerosing agent did not cause small bowel perforation in any case, even if the puncture was too deep occasionally. With a relatively low access threshold, the operation procedure of local submucosal injection is repeatable, maneuverable and time-saving. However, it is critical to limit the therapeutic range no more than 1/2 of the circumferences of intestinal wall to avoid large ulceration and delayed perforation. On the other hand, no other postoperative complications such as overt bleeding, acute pancreatitis, and organ embolism were observed in the EIS group. EIS thus had good safety.

Similar to APC and other methods, EIS cannot also completely prevent recurrent bleeding of SBAs because of the newly formed lesions or missed lesions. Supportive care, iron supplement, and RBC transfusion are still the basic treatment for patients with SBAs. In addition, thalidomide and octreotide have presented some benefits. Repeated endoscopic treatment may increase the effect, but also increase the risk. Thus, patients with SBAs need comprehensive treatment and continuous follow-up management to obtain the best therapeutic effect. However, considering that EIS treatment is a hemostatic method using submucosal injection directly, this technique may be more maneuverable, time-saving, secure for treating SBAs against the conventional techniques; and it may destroy deep lesions more thoroughly. EIS treatment is superior to conservative treatment; and it may be more effective than the conventional techniques including APC for treating SBAs, particularly for multiple lesions and suspected lesions.

Our study also had some limitations. Firstly, this was a single-center, retrospective case-control study. In order to obtain stronger evidence, a multicenter, prospective, randomized, double-blind clinical study with large sample and multiple endoscopic techniques is needed in the future. Secondly, the sample size involved in this study was limited because of the low prevalence of SBAs in adult patients and the strict criteria for enrollment. Thirdly, the significant differences in the age and gender distributions between groups may result in a certain amount of bias; and this may be due to the choice inclination of DBE in the relatively young male patients, given that it allows diagnosis and treatment in the same procedure. However, in this study which enrolled patients with high risk for recurrence, univariate and multivariate analysis (Tables 5 and 6), as well as the results of previous studies, did not suggest age or gender as a significant risk factor for recurrence. Lastly, the limitations of examinations may lead to miss some small bowel lesions.

---

### Chronic GI bleeding in a middle-aged woman [^1168Hwj5]. Gut (2019). Medium credibility.

Answer

Jejunal submucosal aneurysm.

We considered the lesion to be a solid tumour such as a GI stromal tumour and injected India ink nearby to facilitate identification for surgical resection without obtaining a biopsy specimen to avoid uncontrollable haemorrhage. The patient underwent laparoscopic segmental resection. Histopathological examination of the lesion revealed a 5 mm diameter sac-like submucosal arterial aneurysm (figure 2A–C).

Figure 2
Macroscopic view of the cut surface of the resected lesion (A). Histopathological findings of H&E stain (B) and Elastica van Gieson stain (C). The aneurysm contained an organised haematoma and communicated with two arteries but no veins. Abnormal vessels indicative of an arteriovenous malformation were not found.

Submucosal aneurysm of the small intestine is a rare GI vascular lesion originally reported by Levine and Valk. Once bleeding develops, massive haematochezia usually results with a sudden onset, leading to life-threatening haemorrhagic shock. It is quite uncommon to see chronic gentle bleeding such as in our case. As emergency surgery is usually performed before an endoscopic diagnosis has been made, to the best of our knowledge, this is the first case in which endoscopic images of the lesion at haemostasis were obtained, except for one previous report of a ruptured case. According to an endoscopic classification system for small-intestinal vascular lesions, the Yano-Yamamoto classification, this lesion could be classified as type 4. Initially, it may be difficult to identify this lesion as a vascular lesion. Note that obtaining biopsy specimens from SMT-like lesions without first ruling out vascular lesions by endoscopic ultrasonography or other imaging carries a potential risk of massive bleeding.

---

### HFSA / SAEM / ISHLT clinical expert consensus document on the emergency management of patients with ventricular assist devices [^114PHSfz]. The Journal of Heart and Lung Transplantation (2019). High credibility.

Bleeding complications and diagnostic approach in continuous-flow LVAD patients — "Non-surgical bleeding is a common cause of morbidity", with HeartMate II data showing bleeding events "occurred in 19%-40% of patients". Gastrointestinal (GI) bleeding "occurs in approximately 27% of patients with CF LVADs", most commonly from "arteriovenous malformations in either the stomach or duodenum". Patients "are prescribed dual anti-coagulant and anti-platelet therapy". For evaluation, "Initial endoscopy and colonoscopy are recommended", and if no source is found, "push enteroscopy or other methods of evaluating the small bowel are recommended". A published algorithm "advocates push enteroscopy and colonoscopy as first-line investigations for upper and lower GI bleeding, respectively".

---

### Successful treatment of bleeding gastro-intestinal angiodysplasia in hereditary haemorrhagic telangiectasia with thalidomide [^116VLdvd]. BMJ Case Reports (2011). Medium credibility.

Hereditary haemorrhagic telangiectasia (HHT) is an autosomal dominant disorder characterised by epistaxis, cutaneous telangiectasia and visceral arterio-venous malformations (AVMs). It affects approximately one in 5000 people. Control of sustained and repeated haemorrhages from telangiectasias in the nose and gut in patients who may be transfusion dependent is clinically challenging. After repeated endoscopic coagulations, multiple lesions often recur at other sites of gastro-intestinal tract, where endoscopic therapy or surgical resection is not possible. Hormonal therapy has been employed for more than 50 years but has recently been shown to be ineffective. Thalidomide, with its antiangiogenic mechanism of action, seems to be promising drug as a treatment option where other modalities have been unsuccessful. In this article, the authors discuss a novel treatment of bleeding gastro-intestinal angiodysplasia.

---

### Application of epinephrine mixed with local anaesthetics in injection sclerotherapy of early-stage arteriovenous malformation [^11678r1Y]. European Journal of Radiology (2023). Medium credibility.

Purpose

To explore the effect of epinephrine mixed with local anaesthetic injection on blood flow control in early stage arteriovenous malformation (AVM) and explore suitable cases.

Methods

Twenty-five patients with early stage (Schobinger clinical stage I/II) AVM were selected between September 2019 and March 2022. Local anaesthetics containing epinephrine were injected around the nourishing artery and into lesions under the guidance of ultrasound, and the blood flow distribution grade in the lesions as well as the changes in diameter, peak systolic velocity (PSV), and resistance index (RI) of the nourishing arteries and vessels in the lesions were observed to determine the type of AVM suitable for epinephrine injection. After blood flow was controlled, sclerosant agents were injected into the lesions for sclerotherapy.

Results

After local injection of the epinephrine mixture, the blood flow distribution in the lesion decreased by one to three grades; the diameter and PSV also decreased, while RI increased. There were statistically significant differences before and after the injection (P < 0.05). The efficacy of the injection was 80% (20/25), especially in patients with lesion vessels, a nourishing artery lumen diameter < 2 mm, and a PSV < 40 cm/s in the lesion. Patients with Schobinger clinical stage I AWM showed good results.

Conclusions

Local anaesthetics containing epinephrine play a positive role in reducing the distribution and velocity of blood flow in patients with AVM lesions and may be used as an experimental method for the treatment of AVM, which is beneficial for sclerotherapy in patients with early AVM.

---

### Imaging to intervention: a review of what the interventionalist needs to know about hereditary hemorrhagic telangiectasia [^116tDSaf]. CVIR Endovascular (2021). Medium credibility.

Surgical ligation has the same indications and complications as transarterial embolization (Garcia-Tsao et al.). The only curative treatment for hepatic AVMs is orthotopic liver transplant (Garcia-Tsao). The transplant procedure in these patients is particularly difficult due to the increased intraoperative bleeding from AVMs, so a thorough pre-transplant workup is required to minimize risk. Identifying large pulmonary AVMs is crucial to the pre-transplant workup with subsequent treatment of these lesions prior to transplant to prevent risk of hemorrhage (Lerut et al.). The reported post-operative survival rate of liver transplant in HHT is approximately 80% at 58 month follow up (Garcia-Tsao).

Gastrointestinal bleeding

Bleeding in the gastrointestinal (GI) tract is due to telangiectasias in the bowel wall. It most commonly presents as an upper GI bleed and are often multifocal (Jackson et al.). The onset of GI bleeding usually starts after the age of 30 years old and increases with age (Govani and Shovlin). When evaluating a patient for GI bleeds, it is important to note that the fecal occult blood test is non-specific because it can result in a false positive due to swallowed blood from epistaxis. More fool-proof methods for diagnosing GI bleeding from telangiectasias are endoscopy, capsule enteroscopy, angiography, or nuclear medicine tagged RBC scans (Faughnan et al; Jackson et al.). Most often, these GI bleeds can be managed conservatively with antifibrinolytics, octreotide to reduce portal pressures by decreasing splanchnic flow, and aggressive iron therapy with target ferritin goal of greater than 50–100 ng/ml (Lee et al; Houghton et al; Tortora et al.). Areas of bowel with focal bleeding or larger malformations can be treated by endoscopy or resected surgically (Yen and Chen). There is a paucity of literature to support catheter directed embolization in the routine treatment of GI telangiectasias, likely due to the small, multifocal lesions leading to slow-flow, and intermittent bleeding not amenable to embolization.

---

### Arteriovenous malformation of the mandible: embolization and direct injection therapy [^114hAE1r]. Journal of Vascular and Interventional Radiology (2001). Low credibility.

Arteriovenous malformation (AVM) of the mandible is a rare entity but one that can be potentially fatal as a result of massive hemorrhage. Traditional treatment involved extensive surgical resection of the mandible. With the advent of improved endovascular techniques, interventional radiology is now the best method to control active hemorrhage and ultimately cure these lesions. The authors describe three cases of successfully treated mandibular AVM by percutaneous and/or endovascular techniques.

---

### Massive per rectal bleeding in a child due to caecal arteriovenous malformation treated successfully by embolisation [^113eJbWW]. BMJ Case Reports (2013). Medium credibility.

A 12-year-old girl presented with a sudden onset of per rectal bleeding. After admission, she had further episodes of large volume per rectal bleeding and developed hypotensive shock. Hence a massive haemorrhage protocol was activated. Surgical, paediatric and anaesthetic support was sought immediately. Further resuscitation with packed red cells, platelets and fresh frozen plasma was successful. An urgent CT angiogram of the abdomen confirmed active arterial bleeding from an arteriovenous malformation in the caecum. After a detailed discussion between the surgeons and the interventional radiologists, it was decided to attempt therapeutic embolisation first, failing which surgery was the option. The patient and family were fully informed. Through a right femoral approach under local anaesthesia, the superior mesenteric artery was catheterised and the bleeding vessel was successfully controlled with two microembolisation coils. Except for some initial abdominal discomfort, she made an uneventful recovery and was discharged home.

---

### Endovascular embolization of canine hepatic arteriovenous malformations using precipitating hydrophobic injectable liquid (PHIL) liquid embolic agent: a proof of concept study [^115KA53G]. CVIR Endovascular (2019). Medium credibility.

Although HAVMs in dogs and humans differ in terms of relative prevalence and the vessels involved, the overarching similarities in the vascular malformation allows translational experience for imaging and treatment modalities between the two species. HAVMs in humans and dogs are angiographically similar, with a network of arteries connecting to veins via a central nidus, suggesting that embolization techniques are likely to have similar results in both species. In dogs, the communication is between the hepatic artery and portal vein, whereas in humans, communication is typically between the hepatic artery and hepatic vein. (Raj,) As PHIL has been successfully used in the treatment of cerebral and spinal arteriovenous fistulas in humans, its use may be extended to treating hepatic AVMs in the paediatric population. There are a lack of trials exploring the use of PHIL in the human paediatric population, with patients treated with PHIL for cerebral AVMs having a mean age of 58. (Leyon et al.) However, given the dogs in this study are young and of small size, PHIL may potentially be a safe and effective agent for the endovascular embolization of HAVMs in the paediatric population, although the long-term outcomes of treatment with PHIL are yet to be explored.

---

### Small intestine polypoid arteriovenous malformation: a stepwise approach to diagnosis in a paediatric case [^116f5tmL]. BMJ Case Reports (2018). Medium credibility.

We report a case of acute gastrointestinal haemorrhage due to a small intestine polypoid arteriovenous malformation (AVM) in a patient with a remote history of obscure gastrointestinal bleeding (OGIB) 8 years earlier. The diagnosis of a small intestine AVM was made using video capsule endoscopy (VCE) and confirmed using single-balloon push enteroscopy. The lesion was marked with submucosal tattoo to aid in subsequent surgical resection of the lesion with primary duodenoduodenostomy. Since our patient's initial bleeding episode, a variety of advanced tools have become widely available to aid in the localisation of OGIB. This case illustrates the use of a stepwise approach using new medical technology to identify and manage OGIB in children. VCE and push enteroscopy proved to be important diagnostic modalities in this paediatric case.

---

### Thrombosis of pancreatic arteriovenous malformation induced by diagnostic angiography: case report [^114NQ5Fe]. BMC Gastroenterology (2016). Low credibility.

Discussion

Vascular malformations of the gastrointestinal tract are rather uncommon, however, when present they are predominantly found in the liver or in extrahepatic locations; there is less than 1% incidence within the pancreas. In most cases the condition is congenital and found accidentally by diagnostic imaging performed for a different reason. In the present case the PAVM was thought to be congenital due to the absence of acquired factors, such as neoplasm or trauma, and also the negative family history and lack of any vascular dysplastic disease symptoms. The patient's primary symptom of recurrent abdominal pain could be attributed to focal ischemia, since neither bleeding from the PAVM into the pancreatic duct, nor dilatation of the duct was observed.

The standard treatment for PAVM frequently involves surgery, conservative therapy (embolization, sclerotherapy or portal venous shunt), or no treatment at all. Surgical pancreatectomy is still considered to be the sole radical treatment for PAVM despite huge metabolic consequences sustained by the radically or totally pancreatectomized patient. However, as the malformation grows, its abundant vessel network, including feeding arteries and draining veins, often increases the difficulty of surgical haemostatic treatment. Therefore, DSA prior to treatment decisions is helpful in developing the tactics of treatment, even if a diagnosis has been established by non-invasive imaging modalities. In addition, subsequent interventional therapy, i.e. TAE, can be performed after the diagnosis of PAVM by this procedure.

In the presented case, the PAVM, characterized by way of DSA, was relatively small in size, however, branching from numerous small-caliber feeding arterioles. No dominant arteries were found; therefore, coil embolization was not possible. Additionally, TAE by means of ethylene-vinyl alcohol copolymer (Onyx, EV3, USA) was discussed as the only treatment option. In keeping with a conservative treatment approach, it was not performed so as to avoid any undesired wash out of the infused agent to the non-targeted duodenum, which could possibly cause necrosis. Sclerotherapy was also not performed, since we lacked precise initial diagnostic imaging of the vascular malformation, which would have allowed a characterization of its flow dynamics, i.e. high-flow from low-flow. In the end, the patient received no specific treatment at all.

---

### Endovascular approach in the management of idiopathic myointimal hyperplasia of the inferior mesenteric vein [^112U2ArG]. CVIR Endovascular (2021). Medium credibility.

The definitive etiologies of both mesenteric AVM and IMHMV are unknown. It is plausible that AVM and IMHMV are associated, but no previous studies have proven the basis of this association. IMHMV is characterized by smooth muscle proliferation in small and medium-sized mesenteric veins, in essence creating venous arterialization that leads to stenosis and possible occlusion. Thus, prior reports have hypothesized that IMHMV results from an arteriovenous connection that leads to increased pressurization of the veins, resulting in venous arterialization.

Standard treatment for both IMHMV and AVM is surgical resection of the affected section of bowel. The median time from patient presentation and symptom onset to surgical resection is 5 months. However, endovascular embolization has also been shown to be a viable treatment option for arteriovenous connections where the anatomy is amenable. There have not yet been any reports of successful conservative medical treatment for IMHMV. Typically, the diagnosis is missed, and surgery is performed after significant morbidity or failure to respond to IBD medical treatments (Bronswijk et al.).

This case illustrates the possible significance of an arteriovenous connection in the setting of ischemic colitis with a plausible pathogenic relationship with IMHMV. Coupling this case with the previously hypothesized associations with vascular anomalies, early radiologic evaluation for an abnormal arteriovenous connection may facilitate a diagnosis of IMHMV. While embolization did not yield long-term benefit in the presented case, further study is needed to investigate the utility of endovascular approaches as a viable treatment alternative to resection for IMHMV with an abnormal arteriovenous connection, particularly when diagnosed early, as endovascular treatment offers significant benefits (Hendy et al.). Earlier IMHMV identification may also yield earlier diagnosis and improved outcomes for patients with neuroendocrine tumors, which have been shown to be associated with this condition (Guadagno et al.). With increased awareness of the condition, IMHMV can be considered in the differential diagnoses of patients presenting with protracted severe abdominal pain and colitis without a clear infectious or inflammatory etiology.

---

### Exsanguinating upper GI bleeds due to unusual arteriovenous malformation (AVM) of stomach and spleen: a case report [^116vy3bx]. World Journal of Emergency Surgery (2009). Low credibility.

Consent

Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.

---

### Management of pancreatico-duodenal arterio-venous malformation [^1171HDav]. CVIR Endovascular (2022). Medium credibility.

Different embolic agents have been used in previous reports: particles and ethanol were described with good technical success (Frenk et al.), embolization with Onyx® showed complete regression of PDAVMs (Cassinotto & Lapuyade; Grasso et al.), and Glue utilized as well (Tatsuta et al.). Liquid embolic agents are the most useful. Onyx® provides the best control for liquid agent and should be preferred to minimize the risk of non-target embolization (Guimaraes & Wooster). The speed of polymerization of glue is more difficult to predict and the slow injection rate of Onyx® give more chance to the operator to prevent non target embolization (Li & Barthes-Biesel). Glue had a higher risk of bowel infarction and glue reflux into other vessels may result in non-target embolization. On the venous side, the combination of mechanical occlusion with coils or plugs with a liquid agent is recommended (Soulez et al; Lee et al.). Insertion of a covered stent-graft combined with embolization of a venous aneurysm is an elegant approach to maintain the patency of splanchnic veins in case of an aneurysmal draining vein (Yakes IIB, IIIA) (Beyer et al.). Ethanol embolization has the potential to cure the AVM, however it carries a higher-risk of non-target embolization and potential gastroduodenal ulcer or pancreatitis.

Reported complications included gastric ulcer, pancreatitis, portal vein thrombosis, bowel ischemia (Lee). The occurrence of duodenal ulceration following the arterial approach being the most frequent (Cassinotto & Lapuyade; Grasso et al.). Selective TAE with NBCA in the pancreas caused localized ischemic necrosis without clinically significant pancreatitis in a swine model (Okada et al.).

The transvenous approach for PDAVM was not reported yet. This approach carries a risk of portal, mesenteric or splenic vein thrombosis. It is important to control reflux of liquid embolic agent into the portal system by occluding potential re-entry in the portal system. This could be achieved by occluding draining veins connected to the portal system with plugs or coils. Intra-nidal sclerotherapy by direct puncture was not performed because the AVM were deeply located and difficult to image under ultrasound or non-contrast or delayed contrast enhanced CT. Moreover, this requires to puncture through digestive structures in most cases.

---

### Endoscopic injection sclerotherapy for treating recurrent bleeding of small bowel angioectasias [^115ZeCeE]. BMC Gastroenterology (2023). Medium credibility.

Evaluation of safety of the examinations and EIS treatment

No endoscopic adverse events such as overt bleeding, small intestinal perforation, acute pancreatitis, and organ embolism occurred in the patients who underwent DBE examinations and EIS treatments until their discharges. Capsule retention occurred in none of the patients who underwent CE examinations.

---

### Long-time octreotide in an adolescent with severe haemorrhagic gastrointestinal vascular malformation [^113twQuk]. BMJ Case Reports (2011). Medium credibility.

Gastrointestinal vascular malformations are a rare cause of acute or chronic blood loss. Usually they are treated by endoscopic obliteration or surgical resection. When such a therapy is inapplicable, pharmacotherapy may be required. At the age of 15 years, our female patient suffered from transfusion dependent recurrent gastrointestinal haemorrhage due to multiple gastrointestinal vascular malformations. Gastroscopy, coloscopy and capsule endoscopy revealed numerous foci making both endoscopic obliteration and complete surgical resection impossible. Neither regular transfusions nor substitution with coagulation factors were helpful. However, subcutaneous octreotide resulted in immediate stop of bleeding. Initial treatment by daily subcutaneous injections was followed by monthly depot application. Over 3 years only 2 transfusions had to be given. The patient required thyroxin substitution, otherwise, no side effects occurred and the girl had a good quality of life. The authors conclude that octreotide is safe and effective in gastrointestinal angiodysplasias inaccessible to endoscopy or surgery.

---

### A new therapeutic approach to congenital pelvic arteriovenous malformations [^1175EXuH]. Annals of Vascular Surgery (2010). Low credibility.

Background

Internal iliac arteriovenous malformations (AVM) are difficult to treat. Arterial embolization is chosen in most cases but the angio-architecture of these arteriovenous shunts can provide an explanation for the several reported failures. We report the long-term results of peroperative intravenous embolization.

Methods

Between the years 1980 and 2008, seven patients were treated for complex and symptomatic internal AVM. These patients underwent a surgery which involved massive embolization of the venous hypogastric compartment, followed by the ligation of the hypogastric vein at its origin.

Results

There were no deaths reported in this group. The mean follow-up was 7 years (range: 10 months-12 years), with no cases of recurrences found. Computed tomographic scans of controls with reconstruction did not show any residual arteriovenous shunts.

Conclusion

Intravenous embolization of the internal iliac AVM is a therapeutic strategy which is well adapted to the special angio-architecture of the arteriovenous shunts. Clinical and anatomic results have confirmed the validity of this strategy.

---

### Inadvertent accident during balloon-occluded glue injection for facial AVM: rescue procedure using intentional glue injection [^115kzPUU]. CVIR Endovascular (2022). Medium credibility.

Background

Balloon-occluded glue injection has been adopted for various procedures since being introduced (Hamaguchi et al.). It can help flow control and avoid the regurgitation of glue. Its chief complication is the adhesion of the balloon catheter to the vessel walls due to glue reflux. Although several studies have reported strategies to prevent the adhesion of the balloon catheter (Kawai et al; Mine et al.), none have reported a rescue method for balloon adhesion. Herein, we describe a technique we used to extract a stuck microballoon catheter during treatment of a patient for arteriovenous malformation (AVM). The patient provided informed consent and agreed to publish his case details and images.

---

### ACG clinical guideline: diagnosis and management of small bowel bleeding [^115CRUNq]. The American Journal of Gastroenterology (2015). Medium credibility.

Somatostatin analogs — evidence summary notes potential benefit in angiodysplasia, with a 2010 systematic review demonstrating a significant reduction in the need for blood products in 62 patients from three small studies and subsequent reports of response rates for a further 15 patients with angiodysplasia involving the stomach (n = 6), small intestine (n = 9), and colon (n = 3).

---

### Contemporary management of vascular malformations [^1132rDkN]. Journal of Oral and Maxillofacial Surgery (2014). Low credibility.

Purpose

To review the literature on vascular malformations and to clarify their diagnosis, clinical presentation, and treatment options.

Material and Methods

The authors reviewed the current literature on vascular malformations looking for more innovative and credited diagnostic criteria and treatment protocols.

Results

The review is divided in 4 sections (capillary, venous, arteriovenous, and lymphatic malformations). In each section, the clinical presentation, radiologic features, and treatment options for each kind of vascular malformation are described. The experience and results of the authors also are presented.

Conclusions

Vascular malformations are a heterogeneous group of diseases. Each type of malformation has unique features that make it largely different from the others. Only a clear and correct diagnosis can lead to optimal results.

---

### Exsanguinating upper GI bleeds due to unusual arteriovenous malformation (AVM) of stomach and spleen: a case report [^111qc9cE]. World Journal of Emergency Surgery (2009). Low credibility.

Authors' contributions

MIK carried out management of the patient and prepared the manuscript. MTB carried out diagnostic procedures and also helped in drafting the manuscript. MFB helped in preparing manuscript and review of literature. NM carried out Gynaecological management of the patient and helped in drafting the manuscript.

---

### Extravascular injection of sclerotic agents does not affect vessels in the rat: experimental implications for percutaneous sclerotherapy of arteriovenous malformations [^116CWfbp]. European Journal of Vascular and Endovascular Surgery (2012). Low credibility.

Objectives

Sclerotherapy is useful for the treatment of arteriovenous vascular malformations. However, intravascular administration of sclerotic agents into small arteriovenous niduses is often difficult. Extravascular administration of sclerotic agents causes reduction of vascular flow on Doppler echo during clinical sclerotherapy. Therefore, we aimed to investigate whether the extravascular injection of sclerotic agents affects tiny vessels.

Design

Animal study.

Materials

The effect of extravascular injection of sclerotic agents on vessels was investigated using rat femoral and superficial inferior epigastric vessels.

Methods

After surgical exposure of vessels, absolute ethanol, 5% ethanolamine oleate and 3% polidocanol were injected into perivascular surrounding tissues, and their effect on vessels was evaluated after 14 days using histology and coloured silicone rubber injection.

Results

The integrity of the vascular lumen, endothelial cells and vascular patency were not affected by injection of sclerotic agents.

Conclusions

Attenuation of vascular flow of an arteriovenous shunt after extravascular injection of sclerotic agents is transient and/or trivial and does not cause disruption of vessels. Therefore, sclerotic agents should be delivered to obtain sufficient destruction of arteriovenous malformation lesions and blood flow.

---

### Exsanguinating upper GI bleeds due to unusual arteriovenous malformation (AVM) of stomach and spleen: a case report [^117UrGs3]. World Journal of Emergency Surgery (2009). Low credibility.

Introduction

Gastrointestinal bleeding is a commonly encountered emergency. Common causes include bleeding peptic ulcers, gastric erosions and esophageal varices. Rare causes include arteriovenous malformation (AVM) of the gastrointestinal tract. With increasing availability of endoscopy and elective angiography AVM is being more frequently recognized. Literature search shows since 1884 about 42 cases have been reported so far worldwide. Upper GI bleeding caused by AVM usually presents as massive haematemesis or chronic iron deficiency anaemia. Non-specific endoscopic appearances make the diagnosis difficult. Therapeutic embolisation offers a better chance of stopping hemorrhage. However, in emergency situations, surgeon may be forced to perform life saving exploration and procedures if selective angiography is not available or unhelpful and when patient with AVM causing massive haemorrhage required surgical arrest of bleeding.

---

### AGA clinical practice update on management of iron deficiency anemia: expert review [^117PgDiW]. Clinical Gastroenterology and Hepatology (2024). High credibility.

Small-bowel angioectasias and iron-deficiency anemia — In patients undergoing small-bowel evaluation for IDA, angioectasias have a diagnostic yield of 20% to 40%, and a meta-analysis of 14 studies and 623 patients found an overall rebleeding rate of 34% and 45% for small-bowel angioectasias. Radiofrequency ablation is considered experimental and, in a case series, a 20% rebleeding rate over a 6-month period was observed; adjunct medical therapy with somatostatin analogues may reduce transfusion requirements and rebleeding although the evidence is not robust, with octreotide noted to be more effective than lanreotide. There have been 2 randomized controlled trials (RCTs) of antiangiogenic therapy with thalidomide showing reductions in transfusions and rehospitalizations secondary to bleeding and a dose-dependent reduction in rebleeding measured 1 year after treatment, but with significant adverse reactions; therefore, use of antiangiogenic therapy should be reserved for those who have failed all other forms of therapy and should be given by providers with experience with thalidomide.

---

### Treatment of challenging extracranial arteriovenous malformations: a single-center experience and literature review [^112ogNNq]. Annals of Plastic Surgery (2023). Medium credibility.

Abstract

Extracranial arteriovenous malformation (AVM) is a high-flow congenital vascular malformation, where direct communication between the arteries and veins impedes perfusion of capillary beds and causes disfigurement of the affected tissue. Surgery and endovascular therapy are currently the main treatment for extracranial AVMs. Nevertheless, management of complex cases is sometimes challenging because of severe complications such as refractory ulceration, life-threatening bleeding, and even cardiac insufficiency. Here, we reviewed the development and potential treatment for extracranial AVMs and shared our single-center experiences of diagnosis and treatment of this challenging disease.

---

### Exsanguinating upper GI bleeds due to unusual arteriovenous malformation (AVM) of stomach and spleen: a case report [^115KDUrh]. World Journal of Emergency Surgery (2009). Low credibility.

Our patient had a diffuse type of AV malformation involving whole of the stomach as well as spleen which is an unusual occurrence. Attempt to diagnose by endoscopy lead to massive bleeding causing severe haemodynamic instability requiring emergency exploratory laparotomy and total gastrectomy with spleenectomy. AVM are more and more treated by endoscopic and endovascular techniques during the last twenty years but surgery remain a major rescue tool in emergency and treatment option in elective situations.

---

### AGA clinical practice update on management of iron deficiency anemia: expert review [^1113UjB1]. Clinical Gastroenterology and Hepatology (2024). High credibility.

AGA Clinical Practice Update — management of small-bowel angioectasias: Endoscopic treatment of angioectasias should be accompanied with iron replacement, and medical therapy for small-bowel angioectasias should be reserved for compassionate treatment in refractory cases when iron replacement and endoscopic therapy are ineffective.

---

### ACG clinical guideline: diagnosis and management of small bowel bleeding [^116pXmte]. The American Journal of Gastroenterology (2015). Medium credibility.

Small bowel bleeding — Small bowel angiodysplastic lesions remain the most common cause of small bowel bleeding and, despite endoscopic therapy, demonstrate high recurrence rates. Medical therapy with somatostatin analogs or antiangiogenic agents may be an option for refractory patients. Surgical therapy should be reserved for patients requiring lysis of adhesions for successful deep enteroscopy, and aortic valve replacement should be considered for patients with Heyde's syndrome.

---

### Percutaneous treatment of low flow vascular malformations [^112Qr4ku]. Journal of Vascular and Interventional Radiology (2004). Low credibility.

Low flow vascular malformations, especially venous and macrocystic lymphatic malformations, are effectively treated by percutaneous intralesional injection of sclerosant drugs, such as ethanol and detergent sclerosant drugs. Good to excellent results are possible in 75%-90% of patients who undergo serial sclerotherapy. Most adverse effects are manageable, but severe complications can result from the intravascular administration of ethanol. It is generally recommended that the treatment of vascular malformations be performed in a multidisciplinary setting by practitioners with appropriate training and support.

---

### Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the Study of Liver Diseases [^111kETJc]. Hepatology (2017). Medium credibility.

Ectopic varices — epidemiology, diagnosis, and management — are very rare in cirrhosis but a significant source of bleeding in prehepatic portal hypertension, and cases should be evaluated/treated on a case-by-case basis based on vascular anatomy; diagnosis can be made with thin-slice contrast-enhanced computed tomography in the portal venous phase using large-volume diluted water-soluble oral contrast, and the most frequent locations are surgical stomas, duodenum, jejuno-ileum, and colon. Management requires a thorough knowledge of the vascular supply and a multidisciplinary approach; treatment options include ligation, cyanoacrylate injection, endosonographic coil placement, transjugular intrahepatic portosystemic shunt (TIPS) with or without embolization, and balloon-occluded retrograde transvenous obliteration (BRTO), and in stomal varices, direct injection of sclerosing agents or cyanoacrylate under radiographic guidance can be very successful.

---

### ACG clinical guideline: diagnosis and management of small bowel bleeding [^11176Lgd]. The American Journal of Gastroenterology (2015). Medium credibility.

ACG Clinical Guideline — treatment and outcomes recommendations for small bowel bleeding state that if a source of bleeding is found by VCE and/or deep enteroscopy in the small intestine that is associated with significant ongoing anemia or active bleeding, then the patient should be managed with endoscopic therapy (strong recommendation, low level of evidence). If after appropriate small bowel investigation no source of bleeding is found, the patient should be managed conservatively with oral iron or by intravenous infusion as is dictated by the severity and persistence of the associated iron-deficiency anemia, and in this context, a small vascular lesion found on capsule endoscopy does not always need treatment (strong recommendation, very low level evidence). If bleeding persists in either of the above situations with worsening anemia, a further diagnostic workup should include a repeated upper and lower endoscopy, VCE, deep enteroscopy, CT, or MRI enterography as is appropriate for the clinical situation and availability of investigatory devices and radiologic expertise (strong recommendation, low level of evidence). If bleeding persists or recurs and a source lesion cannot be localized consideration may be given to medical treatment with iron, somatostatin analogs, or antiangiogenic therapy (strong recommendation, moderate level evidence). Anticoagulation and/or antiplatelet therapy should be discontinued if possible in patients with small bowel hemorrhage (conditional recommendation, very low level evidence). Surgical intervention in massive small bowel bleeding may be useful, but is greatly aided with previous localization of the bleeding site by marking the lesion with a tattoo (strong recommendation, low level evidence). IOE should be available at the time of the surgical procedure to provide assistance to localize the source of bleeding and to perform endoscopic therapy (conditional recommendation, low level of evidence). Patients with Heyde's syndrome (aortic stenosis and angioectasia) and ongoing bleeding should undergo aortic valve replacement (conditional recommendation, moderate level of evidence). For patients with recurrence of small bowel bleeding, endoscopic management can be considered depending on the patient's clinical course and response to prior therapy (conditional recommendation, moderate level of evidence).

---

### A case of ectopic pancreas in the ileum presenting as obscure gastrointestinal bleeding and abdominal pain [^113b2bR3]. BMC Gastroenterology (2019). Medium credibility.

Usually most cases of bleeding in the small intestine are caused by abnormal blood vessels in the wall of bowel - angioectasias, angiodysplasias, or arteriovenous malformations. However, there are many other possible causes of bleeding in the small intestine, including Crohn's disease, benign and malignant tumors, polyps and ulcers.

Unfortunately, the capsule endoscopy is not reimbursed by Patient Sickness Fund in Lithuania, therefore we performed magnetic resonance (MR) enterography to help visualise possible bleeding site in the small bowel. MR enterography revealed a large pedunculated (attached to the intestinal wall by a 3 cm length pedicle) polyp, measuring approximately 2.5 × 2.3 cm and involving middle third of the ileum (Fig. 1.). Furthermore, ulceration marks at the top of the polyp were described.

Fig. 1
MR enterography: large pedunculated polyp. a Coronal T2-weighted image, mannitol as a luminal contrast, no intravenous contrast. b Axial T2-weighted image, mannitol as a luminal contrast, no intravenous contrast (polyp size 2.5 × 2.3 cm). c Sagittal T2-weighted blade fat saturation (fs) image, mannitol as a luminal contrast, no intravenous contrast (good view of long pedunculus). d Coronal T1-weighted blade image, mannitol as a luminal contrast, no intravenous contrast. e Coronal T1-weighted vibe fs image, intravenous contrast

For further investigation, the patient underwent retrograde single-balloon enteroscopy (SBE) to directly visualize pedunculated polyp, described previously on MR enterography. Examination by SBE revealed a polyp with a long pedicle located approximately 1.5 m distal to the terminal ileum (Fig. 2.). Endoloop-Assisted polypectomy was performed. However, the procedure was complicated with postpolypectomy bleeding from the pedicle. Dilution of adrenaline 20 mL (1/10.000) was injected into the bleeding area and the bleeding was controlled.

---

### A jejunal gastrointestinal stromal tumour: an unusual cause of massive acute gastrointestinal haemorrhage with emphasis on pre intervention MDCT [^113m523F]. Journal of Radiology Case Reports (2009). Low credibility.

Gastrointestinal stromal tumors (GIST) most commonly arise from the stomach followed by the small intestine and are common cause for an occult gastrointestinal (GI) bleeding. We present an unusual case of a jejunal GIST, which presented as an acute gastrointestinal haemorrhage. This case highlights the importance of an intravenous contrast enhanced abdominal CT with neutral oral contrast for the assessment of gastrointestinal bleeding where non-obstructive enhancing tumour, active extravasations and arteriovenous malformations (AVM) could potentially be obscured by the use of positive oral contrast. This case also emphasizes on the use of multiplanar image reconstructions that are extremely useful in determining the exact location and size of the pathology.

---

### Rectal venous malformation treated by superior rectal artery embolization [^112jkgKz]. Cardiovascular and Interventional Radiology (2019). Medium credibility.

A 25-year-old female was referred to the Interventional Radiology Department for investigation and treatment of a rectal venous malformation (RVM) causing large recurrent episodes of rectal bleeding and chronic anaemia. Magnetic resonance imaging (MRI) demonstrated a large venous malformation affecting the rectum, lower pelvis and left thigh. After three failed attempts at injection foam sclerotherapy using fluoroscopic colonoscopy, a multidisciplinary team proposed an embolization procedure of the arterial inflow to the venous malformation. Following discussion with the patient, embolization of the superior rectal arteries was undertaken with immediate on-table fluoroscopic improvement in the RVM. Post-treatment, a significant reduction in bleeding, was reported by day 10 with subsequent return to activities of daily living and full employment. Follow-up MRI at 1 year demonstrated significant reduction in bowel-wall thickening.

---

### Novel motorized spiral enteroscopy: first clinical case [^111KsKuV]. VideoGIE (2016). Low credibility.

Figure 1
A, Integrated electric motor of the novel enteroscope. B, Disposable short spiral overtube and rotation coupler of the insertion tube. C, The spiral overtube is connected to the rotation coupler. D, Prototype spiral enteroscope ready for use. E, Spiral rotation force indicator. F, Insertion of spiral portion of the endoscope. G, Detection of arteriovenous malformation of the jejunum during spiral enteroscopy. H, Treatment of arteriovenous malformation by argon plasma coagulation.

---

### The role of endoscopy in the management of suspected small-bowel bleeding [^114PKoe4]. Gastrointestinal Endoscopy (2017). Medium credibility.

Regarding therapeutic procedures for lower gastrointestinal bleeding, more specifically with respect to angioembolization, ASGE 2017 guidelines recommend to perform angiography for selective embolization in patients with hemodynamically unstable suspected small bowel bleeding, after appropriate hemodynamic resuscitation.

---

### The SNMMI procedure standard / ACNM practice guideline for gastrointestinal bleeding scintigraphy 3.0 [^116Jufzt]. Journal of Nuclear Medicine Technology (2025). High credibility.

Documentation/reporting — report contents for gastrointestinal bleeding scintigraphy should follow structured elements. The first part of the report should identify the study; provide patient demographics, clinical information (indication for the study), and comparison/correlative imaging data; describe the procedure and mention the quality and any limitations of the study. Next, the report should describe the findings, including presence of any baseline vascular, gastrointestinal tract, or solid-organ variants, and characteristics of any abnormal activity (time of onset in relation to injection, shape, intensity in relationship to background liver activity, extent, subjective volume [small, medium, or large], focal or diffuse, stationary activity or movement of activity in gastrointestinal tract [and, if the latter, whether it is curvilinear (small bowel) or linear (large bowel), rapid or slow, and antegrade or retrograde]).

---

### Endoscopic ultrasound-guided vascular therapy: is it safe and effective? [^1164GWq4]. Endoscopy (2012). Low credibility.

Recent developments in therapeutic endoscopic ultrasound (EUS) have enabled new approaches to the management of refractory gastrointestinal bleeding, including EUS-guided sclerotherapy and vessel embolization. Few cases have been reported in the literature. Eight patients were admitted for severe, refractory gastrointestinal bleeding, seven of whom were actively bleeding. Causes of bleeding were gastric varices secondary to portal hypertension (n = 3); gastroduodenal artery aneurysm or fundal aneurysmal arterial malformation (n = 3); and Dieulafoy's ulcer (n = 2); the latter five patients having arterial bleeding. During the procedures, the bleeding vessel was punctured with a 19-gauge needle then injected with a sclerosing agent (cyanoacrylate glue [n = 6] or polidocanol 2% [n = 2]) under Doppler control. The median follow-up time was 9 months (3–18 months). In all 10 endoscopic procedures were performed. The procedure was successful at the first attempt in seven out of eight patients (87.5%). No clinical complications were observed, although in one case there was diffusion of cyanoacrylate in the hepatic artery. The seven successful cases all showed immediate and complete disappearance of the Doppler flow signal at the end of the procedure. This retrospective study highlights the utility of EUS-guided vascular therapy. However, more large randomized studies should be conducted to confirm these results.

---

### ACG clinical guideline: disorders of the hepatic and mesenteric circulation [^112FqiLK]. The American Journal of Gastroenterology (2020). High credibility.

Hereditary hemorrhagic telangiectasia (HHT) liver vascular malformations — In symptomatic liver vascular malformations (LVMs), we recommend standard medical therapy for each complication, with specialized multidisciplinary management for nonresponders; bevacizumab should be considered for high-output heart failure (HOHF) or possibly other LVM complications before invasive therapies, recognizing symptom recurrence after discontinuation and potential significant side effects. Transarterial hepatic artery embolization or surgical ligation is proscribed in patients with biliary involvement or portal hypertension (PH), and there is insufficient evidence to recommend its use in HOHF. Liver transplant is an option for nonresponders or relapsers after medical therapy, but listing criteria are unclear, perioperative complications may be high, and liver VMs may recur as early as 6 yr after transplant (conditional recommendation, low level of evidence).

---

### Nucleoside-modified VEGFC mRNA induces organ-specific lymphatic growth and reverses experimental lymphedema [^116SdbgB]. Nature Communications (2021). High credibility.

VEGFC mRNA-LNP treatment induces organ-specific lymphatic growth after intradermal delivery

Previous studies revealed local production of mRNA-LNP-encoded protein after intradermal delivery. To confirm these findings, C57Bl/6 mice were intradermally injected with 1 µg of GFP mRNA-LNPs in the back skin (or the ear in separate animals), and GFP expression was monitored in the injected back skin or ear, lung, and small intestine. While strong local GFP signal was present at the sites of injections in the back skin or ear and there was no detectable GFP protein in the lung and small intestine of the same animal (Supplementary Fig. 6).

To further confirm local protein production and rule out potential off-target effects after intradermal mRNA-LNP delivery, 1 µg or 5 µg of VEGFC mRNA-LNP was administrated to the back skin (or in a separate experiment to the ear) and lymphatic growth was monitored in the ears, back skin, lung, and small intestine of the same animal by fluorescent microscopy and flow cytometry 21 days after the treatment (Fig. 4a–c). VEGFC-induced lymphangiogenesis was limited to the injection sites (back skin or injected ear) and no lymphatic growth was detectable in other organs including the other ear (non-injected), lung, and small intestine shown by fluorescent microscopy (Fig. 4a–b) and flow cytometry (Fig. 4c). These results indicate that the nucleoside-modified VEGFC mRNA-LNP platform induces local VEGFC secretion and organ-specific lymphatic growth in the ear or back skin after intradermal delivery.

---

### Pharmacological treatment of gastrointestinal bleeding due to angiodysplasias: a position paper of the Italian Society of Gastroenterology (SIGE) [^111sc6Po]. Digestive and Liver Disease (2018). Low credibility.

Angioectasias (AD) belong to benign vascular malformations of the gastrointestinal tract and are responsible for about 4–7% of upper non variceal bleeding, 30–40% of small bowel occult bleeding and 3–40% of colonic bleeding episodes. Gastrointestinal haemorrhage secondary to AD represents an important diagnostic and therapeutic problem that negatively impacts on the quality of life of patients and heath care costs. Endoscopic interventions are the mainstay in both diagnosis and treatment of vascular malformations. However, in a substantial percentage of the cases, age of the patients, comorbidities, clinical severity of anaemia and blood loss as well as size, site and number of lesions prevent this therapeutic approach. Hormonal therapy, thalidomide and somatostatin analogues have been investigated for their potential role as rescue therapies in controlling AD bleeding although, thus far, no recommendations have been provided on their use in this clinical setting. In order to implement appropriate prescription of pharmacological agents to manage gastrointestinal bleeding due to ADs, the Italian Society of Gastroenterology (SIGE) nominated a panel of experts who reviewed the available clinical literature and produced practical clinical recommendations.

---

### Outcome of capsule endoscopy in determining indication and route for push-and-pull enteroscopy [^116dxZ8F]. Endoscopy (2006). Low credibility.

Background and Study Aim

Video capsule endoscopy and push-and-pull enteroscopy (PPE), both allow a complete examination of the small bowel in patients with suspected intestinal disorders. Due to the invasiveness of PPE, indications should probably be selective. The aim of the present prospective study was to evaluate the outcome of an approach whereby capsule endoscopy was used to select patients in whom PPE was indicated.

Patients and Methods

164 patients were included (90 men; age 54 ± 18 years) with various indications for small-bowel investigation, such as obscure bleeding (n = 88), suspected Crohn's (n = 14) or celiac (n = 12) disease, or known or strongly suspected localized diseases such as neoplasms (n = 18) for biopsy. Four patients with a suspected intestinal stenosis underwent PPE without prior capsule endoscopy. In the remaining 160 patients, who had a capsule endoscopy, PPE was selected if there were lesions requiring biopsy or angiodysplasias to be treated by argon plasma coagulation (APC). Regarding the insertion route, an anal PPE was indicated if the capsule transit time from ingestion to arrival at the lesion was ≥ 75% of the total time from ingestion to arrival at the cecum. After gut cleansing, PPE was performed with general anesthesia, and the small bowel was examined until the lesion was reached or the scope could not be advanced further. If the suspected lesion had not been reached, a second procedure was performed through the alternative route, under the same conditions.

Results

The diagnostic yield of capsule endoscopy was 75%. According to the indications, 47 PPE procedures were performed in 42 patients, including 33 through the oral route, 4 through the anal route and 5 combined ones. Indications were: suspicion of intestinal tumor (n = 13), celiac disease with chronic bleeding (n = 4), suspicion of Crohn's disease (n = 3), treatment of significant arteriovenous malformations (AVMs) (n = 10), diffuse enteropathies (n = 3), nonsteroidal anti-inflammatory drug (NSAID)-related conditions (n = 2), and obscure digestive bleeding (n = 3). Lesions detected by capsule endoscopy were reached by PPE in all but two cases. The positive predictive value (PPV) of capsule endoscopy to make a correct indication for PPE was 94.7% and the negative predictive value (NPV) was 98.3%. The PPV and NPV of a time index of > 0.75 to start via the anal route were 94.7% and 96.7%. No complications were observed and all patients were discharged the day after the procedure. Follow-up at 9 months showed that capsule endoscopy followed by PPE had positively influenced the management of 90.5% of the patients.

Conclusions

The use of capsule endoscopy as a filter for PPE results in effective management of patients with various intestinal diseases. Capsule endoscopy can also direct the choice of route of PPE; a time index of > 0.75 appears to reliably indicate an anal route so that a double procedure is required in only about 12% of cases.

---

### Pelvic arteriovenous malformation treated by transarterial glue embolisation combining proximal balloon occlusion and devascularisation of multiple feeding arteries [^1111WTwP]. BMJ Case Reports (2014). Medium credibility.

We present a case of a 70-year-old man with abdominal aortic aneurysm and coincident pelvic arteriovenous malformation (AVM). Before the operation for the aneurysm, we embolised the pelvic AVM that had multiple feeding arteries and an aneurysmal-dilated draining vein. After decreasing the number of the feeding arteries by coil embolisation, an n-butyl-2-cyanoacrylate/lipiodol mixture (1:1) was injected into the prominent feeding artery and nidus with proximal balloon occlusion of the right internal iliac artery to decrease the flow to the nidus. The mixture (1:4–8) was also added for the finer feeding arteries that became apparent after the initial procedure to embolise the rest of the nidus. A follow-up study showed no contrast enhancement of the nidus and aneurysmal draining vein.

---

### Direct percutaneous abdominal venous access for endovascular therapy [^112zvenj]. Journal of Vascular Surgery: Venous and Lymphatic Disorders (2025). Medium credibility.

Fig 1
Patient 2 had a history of portosystemic shunt requiring portal pressure measurement before surgical ligation. (A) Ultrasound image depicting the needle placed via the abdominal wall into dilated inferior mesenteric vein. (B) Portomesenteric venography showing dilated inferior mesenteric vein (short arrow) with retrograde flow to the right internal iliac vein (long arrow).

Fig 2
Patient 1 had a history of portomesteric thrombosis requiring portal pressure measurement before splenorenal shunt surgery. (A) Venous phase celiac arteriography showed faint opacification of the gastric and intestinal draining veins with no visualization of the main portomesenteric veins. Note the displacement of the stomach and liver by the large upper abdominal venous malformation and splenomegaly. (B) Venography through direct access depicting dilated superior mesenteric vein terminating in portal vein collaterals without opacification of the main portal vein.

Fig 3
Patient 4 had a complex ileocolic arteriovenous malformation (AVM). Angiography in the arterial (A) and venous (B) phases demonstrating a complex arteriovenous fistula between dilated ileocolic and right colic arteries and aneurysmal ileocolic vein. (C) Venography via direct access demonstrating the complexity of the ileocolic draining vein. (D) Postembolization angiography showing no residual arteriovenous shunting.

In cases of markedly dilated tributaries of the internal iliac veins associated with large pelvic AVMs, standard femoral arterial access and angiography were initially performed. Retrograde transfemoral cannulation was used for angiography and embolization of the immediate draining veins, which were tributaries of the internal iliac veins (Fig 4). Retrograde transvenous access was sometimes challenging owing to tortuous anatomy, unfavorable angles from femoral or jugular approaches, and the complex angioarchitecture of markedly dilated draining veins (Fig 4). In such cases, selective cannulation of the target vein was time consuming or not achievable, which increased procedural and radiation times. Direct percutaneous access was therefore used to achieve stable catheterization and effective embolization.

---

### Endovascular treatment in the multimodality management of brain arteriovenous malformations: report of the Society of Neurointerventional Surgery standards and guidelines committee [^112YDyKx]. Journal of Neurointerventional Surgery (2022). High credibility.

Brain arteriovenous malformations — treatment planning and role of endovascular embolization centers on individualized goals and multidisciplinary care. Once the decision for AVM treatment has been made, neurovascular centers typically determine whether single modality or multimodality treatment will be most appropriate, the first consideration is whether the AVM is ruptured or unruptured, and the goal of treatment — AVM cure (ie, elimination of the nidus and arteriovenous shunting) versus partial treatment targeting a high-risk feature versus palliation of AVM-related symptoms — is defined; angioarchitecture, location, and local modality-based expertise are key factors. It is recommended that endovascular embolization of cerebral AVMs be performed in the context of a complete multidisciplinary treatment plan aiming for obliteration of the AVM and cure. (I, B-NR).

---

### Amplatzer stuffing technique in the treatment of an iatrogenic mesenteric arteriovenous fistula [^117QYBaP]. Cardiovascular and Interventional Radiology (2009). Low credibility.

We describe a novel technique for placement of an Amplatzer Vascular Plug I in a relatively short space. A mesenteric, relatively large-caliber, iatrogenic, high-flow arteriovenous fistula associated with a pseudoaneurysm was successfully closed using a single vascular plug. The "stuffing technique" allowed us to place a second plug within a very limited residual fistula tract, avoiding the plug extending parent vessels.

---

### Arteriovenous malformation and gastrointestinal bleeding in patients with the heartMate II left ventricular assist device [^1138gf4T]. The Journal of Heart and Lung Transplantation (2011). Low credibility.

Background

In this study we investigated gastrointestinal (GI) bleeding and its relationship to arteriovenous malformations (AVMs) in patients with the continuous-flow HeartMate II (HMII) left ventricular assist device (LVAD).

Methods

The records of 172 patients who received HMII support between November 2003 and June 2010 were reviewed. Patients were considered to have GI bleeding if they had 1 or more of the following symptoms: guaiac-positive stool; hematemesis; melena; active bleeding at the time of endoscopy or colonoscopy; and blood within the stomach at endoscopy or colonoscopy. The symptom(s) had to be accompanied by a decrease of > 1 g/dl in the patient's hemoglobin level. The location of the bleeding was identified as upper GI tract, lower GI tract or both according to esophagogastroduodenoscopy, colonoscopy, small-bowel enteroscopy or mesenteric angiography. Post-LVAD implantation anti-coagulation therapy consisted of warfarin, aspirin and dipyridamole.

Results

Thirty-two of the 172 patients (19%) had GI bleeding after 63 ± 62 (range 8 to 241) days of HMII support. Ten patients had GI bleeding from an AVM; these included 3 patients who had 2 bleeding episodes and 2 patients who had 5 episodes each. Sixteen patients had upper GI bleeding (10 hemorrhagic gastritis, 4 gastric AVM, 2 Mallory-Weiss syndrome), 15 had lower GI bleeding (6 diverticulosis, 6 jejunal AVM, 1 drive-line erosion of the colon, 1 sigmoid polyp, 1 ischemic colitis) and 1 had upper and lower GI bleeding (1 colocutaneous and gastrocutaneous fistula). All GI bleeding episodes were successfully managed medically.

Conclusions

Arteriovenous malformations can cause GI bleeding in patients with continuous-flow LVADs. In all cases in this series, GI bleeding was successfully managed without the need for surgical intervention.

---

### ACG clinical guideline: diagnosis and management of small bowel bleeding [^112C4As7]. The American Journal of Gastroenterology (2015). Medium credibility.

Small bowel angioectasia — rebleeding rates and risk factors after endoscopic therapy are reported as follows: at 12 months, 43% of 101 patients reported no further overt bleeding, 23% recurrent overt bleeding, and 35% ongoing iron and/or transfusion requirements; at a mean of 30 months among 85 interviewed, 50 (59%) reported no overt bleeding or iron/transfusion needs, 20 (24%) further overt bleeding, and 15 (18%) ongoing iron and transfusion requirements; a meta-analysis of 14 studies including 623 subjects treated with endoscopic therapy showed a pooled rebleeding rate of 34% (95% CI, 27–42%) after a mean of 22 ± 13 months, increasing to 45% when 341 patients with small bowel angioectasia were analyzed; risk factors for recurrent bleeding have included the number of vascular lesions, age over 65 years, lesions in the jejunum, cardiovascular disease, chronic renal disease, usage of anticoagulant medication, and need for transfusion; and pilot studies have demonstrated that decreased levels of von Willebrand factor are predictive of recurrent bleeding from small bowel angioectasia in patients with left ventricular assist devices.

---

### ACG clinical guideline: diagnosis and management of small bowel bleeding [^115V9fAc]. The American Journal of Gastroenterology (2015). Medium credibility.

Epidemiology and natural history of small bowel bleeding — summary statements indicate that the type of lesion responsible for small bowel bleeding is dependent on patient age but not gender or ethnicity; small bowel angioectasia are the most common cause; risk factors for angioectasia include advancing age, aortic stenosis, chronic renal failure, left ventricular assist devices, and other hereditary disorders; and risk factors for recurrent small bowel bleeding from angioectasia include number of lesions, advanced age, comorbid conditions, and anticoagulant therapy.

---

### Endovascular treatment in the multimodality management of brain arteriovenous malformations: report of the Society of Neurointerventional Surgery standards and guidelines committee [^115gk6Xt]. Journal of Neurointerventional Surgery (2022). High credibility.

Transvenous embolization for AVM cure — scope and indications: More recently, a limited number of series have been published describing outcomes for embolization to cure using the transvenous approach, and these series have typically included select nidus characteristics and reasonably low complication rates. Proposed indications for this approach include a small (diameter < 3 cm) and compact AVM nidus, deep or eloquent AVM location, hemorrhagic presentation, single draining vein, inaccessible arterial pedicles, exclusive arterial supply by perforators.

---

### Endoscopic therapy for gastrointestinal angiodysplasia [^113MJ3bB]. The Cochrane Database of Systematic Reviews (2024). Medium credibility.

Objectives

This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the benefits and harms of the different endoscopic management approaches for gastrointestinal angiodysplasia in symptomatic adults.

---

### ACG clinical guideline: diagnosis and management of small bowel bleeding [^114vQszj]. The American Journal of Gastroenterology (2015). Medium credibility.

ACG Clinical Guideline — Treatment and outcomes for small bowel bleeding recommends that if a source of bleeding is found by VCE and/or deep enteroscopy in the small intestine that is associated with significant ongoing anemia or active bleeding, then the patient should be managed with endoscopic therapy. If after appropriate small bowel investigation no source of bleeding is found, the patient should be managed conservatively with oral iron or intravenous iron infusion as is dictated by the severity and persistence of the associated iron-deficiency anemia, and in this context, a small vascular lesion found on capsule endoscopy does not always need treatment.

---

### Multi-detector row CT angiography with direct intra-arterial contrast injection for the evaluation of neurovascular disease: technique, applications, and initial experience [^1157B6Fp]. AJNR: American Journal of Neuroradiology (2009). Low credibility.

The purpose of this study was to evaluate the usefulness of 64-section multi-detector row CT angiography (CTA) with direct intra-arterial contrast injection (IA-CTA) for the evaluation of neurovascular disease. This technique was used in 11 patients at our institution. All studies were technically successful, and there were no complications. Small vascular malformations were mapped easily on high-resolution IA-CTA images, enabling microsurgical resection or stereotactic radiosurgery. In a similar fashion, additional morphologic features were revealed on IA-CTA images not seen on standard 2D and 3D digital subtraction angiography. Of 11 patients undergoing IA-CTA, 7 patients had further anatomic clarity of the small arteriovenous fistula/malformation and 4 patients had changes in the treatment plan on the basis of the IA-CTA findings.

---

### Frequency and risk factors for rebleeding events in patients with small bowel angioectasia [^114ksUbw]. BMC Gastroenterology (2014). Low credibility.

Discussion

Herein, we have presented the results of a relatively large, long-term, cohort study on bleeding from small bowel angioectasia. Our aim was to evaluate the significance of endoscopic treatment and determine the long-term outcomes in patients with small bowel angioectasia. It is worthy of note that in contrast to the case in previous studies, we excluded patients with other vascular lesions such as Dieulafoy's lesions, varices and anteriovenous malformations from the analyses, so as to obtain important information on the optimal management of bleeding from small bowel angioectasia.

There are several reports of studies carried out to evaluate the outcomes of patients with OGIB after the initial episode of bleeding. According to these reports, the long-term rebleeding rates ranged widely from 17% to 40%. This could be explained by the heterogeneity in the study population and differences in the duration of follow-up, management strategies and definition of rebleeding among studies. Importantly, the reported rebleeding rates associated with vascular lesions are higher than those associated with other lesions, such as erosions/ulcers and tumors. Consistent with previous reports, we confirmed a relatively high rebleeding rate (33.8%) in patients with small bowel angioectasia.

---

### Polypoid arteriovenous malformation in the jejunum of a child that mimics intussusception [^11534523]. Journal of Pediatric Surgery (2010). Low credibility.

Polypoid arteriovenous malformations, which are localized in the colon, are extremely rare in adults, with only 7 cases published to date. Here we present the case of a 6-year-old girl with a jejunal polypoid tumor that a sonogram and a computed tomographic scan have shown to resemble intussusception. Histologically, numerous large ectatic veins intermixed with small-caliber arteries, venules, arterioles, and capillaries were observed in the intestinal wall. A retrospective computed tomographic scan 3-dimensional angiographic reconstruction demonstrated that this may be a diagnostic characteristic. Clinical and morphologic comparisons with previously reported cases were discussed.

---

### Management of small bowel angioectasias diagnosed during video capsule endoscopy [^116avUyr]. Annals of Gastroenterology (2023). Medium credibility.

Small bowel angioectasias (SBA) are vascular malformations consisting of thin-walled, dilated capillaries located in the gastrointestinal mucosa. They are responsible for 10% of all causes of gastrointestinal bleeding and 60% of small bowel bleeding pathologies. The diagnosis and management of SBA depend upon bleeding acuity, patient stability and patient characteristics. Small bowel capsule endoscopy is a relatively noninvasive diagnostic approach ideal for non-obstructed and hemodynamically stable patients. It is superior to computed tomography scans in visualizing mucosal lesions, such as angioectasias, as it provides mucosal views. Management of these lesions will depend on the patient's clinical condition and associated comorbidities, and very often consists of medical and/or endoscopic treatment delivered through small bowel enteroscopy.

---

### Management of brain arteriovenous malformations: a scientific statement for healthcare professionals from the American Heart Association / American stroke association [^114Y9HXj]. Stroke (2017). Medium credibility.

Digital subtraction angiography in brain arteriovenous malformations — diagnostic role, timing, and risks — is described as the reference standard that delivers the most detailed angioarchitectural and hemodynamic information; once computed tomography (CT) or magnetic resonance (MR) identifies or suspects a bAVM, DSA is generally pursued, and it is often performed after negative CT and MR in patients presenting with intracerebral hemorrhage (ICH). DSA has the highest degree of both spatial and temporal resolution among diagnostic imaging modalities. Immediate risks primarily involve thromboembolic stroke and are described as low, and DSA also entails radiation exposure because high frame rates, magnified views, and multiple injections may lead to high doses to the head and lens of the eye. Given these factors and the need for highly specific angioarchitectural information, DSA may be best performed by members of the cerebrovascular team contemplating treatment.

---

### Inadvertent accident during balloon-occluded glue injection for facial AVM: rescue procedure using intentional glue injection [^115yCRBa]. CVIR Endovascular (2022). Medium credibility.

Discussion

AVMs are congenital vascular malformations developed by defects of arterial and venous origins that result in direct communications between vessels of different sizes or primitive reticular networks of dysplastic vessels that have failed to mature into "capillary" vessels called "nidus" (Lee et al.). AVMs have angiographic classification, proposed by Do et al. (Cho et al; Ko et al.). According to this, our case was AVM type IIIb, which had multiple shunts between the arterioles and venules with dilated fistulae. Direct puncturing of the dilated fistula and injecting ethanol have been proven to be effective, and induced fewer skin complications than transarterial injection (Park et al.). During the last sessions, we performed transarterial and direct puncture alcohol injections. However, these did not work due to the very high velocity of AMVs. Thus, we planned to use a transvenous approach and perform embolization using balloon-occluded glue injection to slow down the velocity and maximize the efficiency of alcohol.

Balloon-occluded glue injection, called the B-glue technique, was introduced by Hamaguchi et al. (Hamaguchi et al.). This demonstrated many advantages over the flow-dependent technique. It can demonstrate better control of embolus range and less reflux. Moreover, it can also help prevent proximal embolization and distal migration. That said, it has a greater pullback resistance than the flow-dependent technique when reflux occurs due to a larger adhesion area than the usual microcatheter. Furthermore, it is important to remove the microballoon catheter immediately upon reflux detection. In our case, it was performed in venous system and we had no choice but to wait for the polymerization of glue to prevent migration to systemic blood flow.

Several studies have been reported on the prevention of glue reflux and balloon adhesion during the B-glue technique. Mine et al. reported that glue injection via distally advanced microcatheter inserted in the inflated microballoon catheter decreased the risk of glue adhesion to the balloon surface compared with direct injection via a microballoon catheter (Mine et al.). Moreover, Kawai et al. reported that adding ethanol to glue and iodized oil mixture can render microcatheter adhesion negligible. They assumed that rapid completion of N-butyl cyanoacrylate (NBCA) sclerosis by adding ethanol was the cause of the minimal adhesion of NBCA to the catheter (Kawai et al.). However, no reports have been published describing rescue method after adhesion of balloon catheters.

---

### Endovascular treatment in the multimodality management of brain arteriovenous malformations: report of the Society of Neurointerventional Surgery standards and guidelines committee [^1159uYkF]. Journal of Neurointerventional Surgery (2022). High credibility.

Embolization to cure brain AVMs — selection criteria and outcomes: Embolization with intent for angiographic cure is, in most centers, reserved for small to medium size lesions with compact niduses, fewer superficial and draining deep venous outlets, and venous pedicles from a single vascular territory, and earlier series using these criteria (SM I, II and III) have been published showing occlusion rates of up to 96% with low complication rates when conducted in high volume centers. In one series, Katsaridis et al identified 101 patients who underwent a total of 219 sessions of embolization over a 4 year period; treatment was concluded in 52/101 patients of which 28 achieved total AVM exclusion, while the remaining 49 patients were planned to undergo further embolization, and procedural morbidity and mortality rates of 1.4% and 1.5%, respectively, were reported. A systematic review published in 2019 identified 15 studies comprising 597 patients with 859 AVMs, with an angiographic cure rate of 58.3% and overall clinical complication and procedure-related mortality rates of 2.4% and 1.5%, respectively.

---

### Intermittent balloon occlusion to favor nidal penetration during embolization of arteriovenous malformations: a technique modification [^114L31nr]. BMJ Case Reports (2013). Medium credibility.

Endovascular embolization of brain arteriovenous malformations (AVMs) has improved with liquid occlusive agents, but flow-related and anatomic restrictions limit endovascular capabilities. AVM compartments supplied by leptomeningeal networks and feeding arteries too small and/or tortuous for safe catheterization are rarely penetrated by liquid occlusive agents. A case with both impediments prompted a novel solution. A balloon was inflated across the supply to a lenticulostriate feeder, thereby favoring penetration of the liquid occlusive agent, injected from a different feeding territory, back into the AVM compartment supplied by the temporarily occluded feeder. This technique may reduce the number of embolization stages in large high-flow AVMs and increase the likelihood of achieving complete occlusion. This technique is highly complex and requires meticulous monitoring of multiple events.

---

### ACG clinical guideline: disorders of the hepatic and mesenteric circulation [^116AgDxd]. The American Journal of Gastroenterology (2020). High credibility.

Hereditary hemorrhagic telangiectasia (HHT) with symptomatic liver VMs — management recommendations state: We recommend standard medical therapy for each complication of liver VMs in patients with HHT, which results in symptom improvement in the majority; in nonresponders to standard therapy, management should be undertaken at specialized centers using a multidisciplinary approach; bevacizumab could be considered in patients with H0HF and possibly for other complications of LVM before using invasive therapies, although not all patients respond, and symptoms recur after treatment discontinuation and bevacizumab can be associated with significant side effects; transarterial hepatic artery embolization or surgical ligation is proscribed in patients with biliary involvement or PH, and there is insufficient evidence to recommend its use in H0HF; liver transplant is an important option for nonresponders to standard treatment or patients who relapse after medical treatment, but criteria for listing are not clearly defined, the procedure may be associated with a high rate of perioperative complications, and LVMs may recur as early as 6 years after transplant (conditional recommendation, low level of evidence).

---

### ACG clinical guideline: diagnosis and management of small bowel bleeding [^116n9Bk4]. The American Journal of Gastroenterology (2015). Medium credibility.

ACG Clinical Guideline — recommendation statements for persistent or recurrent small bowel bleeding and related management state: If bleeding persists in either of the above situations with worsening anemia, a further diagnostic workup should include a repeated upper and lower endoscopy, video capsule examination, deep enteroscopy, CT or MRI enterography as is appropriate for the clinical situation and availability of investigative devices (strong recommendation, low level of evidence). If bleeding persists or recurs or a lesion cannot be localized consideration may be given to medical treatment with iron, somatostatin analogs, or antiangiogenic therapy (strong recommendation, moderate level of evidence). Anticoagulant and/or antiplatelet therapy should be discontinued if possible in patients with small bowel hemorrhage (conditional recommendation, very low level of evidence). Surgical intervention in massive small bowel bleeding may be useful, but is greatly aided with presurgical localization of the site of bleeding by marking the lesion with a tattoo (strong recommendation, low level of evidence). Intraoperative enteroscopy should be available at the time of the surgical procedure to provide assistance to localize the source of bleeding and to perform endoscopic therapy (conditional recommendation, low level of evidence). Patients with Heyde's syndrome (aortic stenosis and angioectasia) and ongoing bleeding should undergo aortic valve replacement (conditional recommendation, moderate level of evidence). For patients with recurrence of small bowel bleeding, endoscopic management can be considered depending on the patient's clinical course and response to prior therapy (conditional recommendation, moderate level of evidence).

---

### Japanese clinical practice guidelines for vascular anomalies 2017 [^116kKDTM]. The Journal of Dermatology (2020). Medium credibility.

As a result of database searching, 11 papers in English were adopted through primary and secondary screening. All papers selected by these screening processes were case reports or case series, and the strength of evidence is D (very weak).

There is no clear standard as to when the examinations should be initiated. However, neonates who developed gastrointestinal bleeding shortly after birth have been reported, 270 and the earliest possible examinations are necessary if this disease is suspected. Invasive examinations are difficult to perform in small children, but blood tests (presence or absence of anemia or consumption coagulopathy) and fecal occult blood tests can be performed. If gastrointestinal bleeding is suspected, procedures such as endoscopy, particularly double‐balloon endoscopy and capsule endoscopy, 99m Tc‐labeled red blood cell scintigraphy and 99m Tc‐labeled red blood cell SPECT‐CT have been reported to be useful for the determination of the source of bleeding. 266, 268, 271, 275

If no abnormality has been detected by screening tests, and if a search for gastrointestinal lesions needs to be performed non‐emergently to diagnose this disease or evaluate the future risk of bleeding, there is no standard for the timing, which may vary among facilities. Among the above examinations, CT and MRI can be performed earlier and with relatively milder invasion, and are worth attempting if this disease is suspected. The necessity of the other examinations for the gastrointestinal lesions mentioned above should be considered when the patient reaches the age that tolerates the examinations.

---

### AGA clinical practice update on interventional EUS for vascular investigation and therapy: commentary [^112aswUM]. Clinical Gastroenterology and Hepatology (2023). High credibility.

Experimental EUS-guided interventions and prerequisites — Preclinical (porcine) studies have demonstrated that a self-expanding metal stent can be deployed via EUS to function as a portosystemic shunt. There are 2 prerequisites to demonstrate the clinical utility of EUS-guided vascular interventions: a vascular target in or near the gastrointestinal wall and demonstrating a clinical efficacy and safety profile comparable, if not superior, to current alternatives. EUS-guided coil injection therapy of gastric varices makes the strongest case for inclusion at centers of expertise, whereas other uses (rectal and ectopic varices, splenic artery embolization, and treatment of arterial bleeding) have been reported in small case series and require further supporting studies.

---

### Re-bleeding and its predictors after capsule endoscopy in patients with obscure gastrointestinal bleeding in long-term follow-up [^1136aU6t]. BMC Gastroenterology (2019). Medium credibility.

CE findings and interventions

Out of the 133 patients, 56 (42.1%) were CE positive (P2 lesion). Nine patients had P1 lesion and 68 patients had P0 lesions. The P2 lesions were identified as small bowel ulcers (20), angiodysplasia (17), small bowel tumors (10) and abnormal vessels (9).

In 35 (62.5%) patients with positive CE, specific treatments were performed, which included therapeutic DAE, embolization, surgical treatment and medication treatment (Table 2). DAE with hemostatic treatments; with either argon-plasma coagulation or electrocoagulation; were performed in 14 patients with angiodysplasia. Hemoclips were applied for abnormal vessels and Dieulafoy's lesions in two patients. Surgical treatments, with or without intraoperative enteroscopy, were performed in eight patients with small bowel tumor, for example, gastrointestinal stromal tumor, adenocarcinoma of the small intestine and in two patients with arteriovenous malformation. An angiogram with embolization was performed on two patients with abnormal vessels. Seven patients received medication treatment. Five patients with NSAID-associated small bowel ulcers received rebamipide. Thalidomide was used as the anti-angiogenic agent in one patient with angiodysplasia, who was suspected as having hereditary hemorrhagic telangiectasia, and one patient with diffused small bowel ulcers, being diagnosed as Crohn's disease, received prednisolone and azathioprine.

Table 2
Specific treatments performed for each type of lesion in patients with positive CE

CE capsule endoscopy, NSAIDs non-steroidal anti-inflammatory drugs

Twenty-one patients with positive CE, who did not receive specific treatments, included 14 patients with small bowel ulcers without active bleeding, three patients with inactive abnormal vessels and two patients with angiodysplasia. Those patients decided to wait and see during follow-up. However, two additional patients with small intestinal tumors (gastrointestinal stromal tumor of the jejunum and appendix tumor) refused to receive aggressive surgical treatment, due to old age and the high risk of surgery.

In patients with negative CE, DAE and embolization were performed in four patients, because of active bleeding and an unstable hemodynamic status. Other patients with negative CE and inactive bleeding received conservative treatment.

This study showed the diagnostic yield of CE was higher in patients with overt OGIB than those with occult OGIB (50.6% versus 28.8%, P = 0.02).

---

### Large congenital pelvic arteriovenous malformation and management options [^1167TT4R]. Urology (2006). Low credibility.

The congenital pelvic arteriovenous malformation (AVM) arises from dysplastic arteries and veins. These rare conditions might present to the urologist by producing massive hematuria. Most AVMs can be controlled by surgical resection, usually in conjunction with preoperative angiographic embolization. Here, we present a case of a large pelvic AVM that caused significant patient morbidity and required treatment by novel methods after the usual means had failed. In this report, we will detail those unique interventions required to control a tenuous clinical situation.

---

### Endoscopic full-thickness resection of a right colonic polypoid arteriovenous malformation [^1177opSr]. VideoGIE (2023). Medium credibility.

Video 1Endoscopic full-thickness resection of a right colonic polypoid arteriovenous malformation.

---

### Inadvertent accident during balloon-occluded glue injection for facial AVM: rescue procedure using intentional glue injection [^116Yp1uJ]. CVIR Endovascular (2022). Medium credibility.

Conclusions

In conclusion, this intentional glue casting technique is very useful when removing anything inside the catheter and removing things stuck due to the glue reflux. It can be applied to various similar emergency situations.

---

### Small intestine cancer treatment-NCI… [^112KWfuT]. NCI (2004). Low credibility.

An endoscope is inserted through the mouth and into the esophagus, stomach, and duodenum. An endoscope is a thin, tube-like instrument with a light and a lens for viewing. It may also have a tool to remove tissue samples, which are checked under a microscope for signs of cancer. Capsule endoscopy: A procedure to look at the inside of the small intestine. A capsule that is about the size of a large pill and contains a light and a tiny wireless camera is swallowed by the patient. The capsule travels through the digestive tract, including the small intestine, and sends many pictures of the inside of the digestive tract to a recorder that is worn around the waist or over the shoulder. The inside tube is moved through part of the small intestine and a balloon at the end of it is inflated to keep the endoscope in place.

Next, the outer tube is moved through the small intestine to reach the end of the endoscope, and a balloon at the end of the outer tube is inflated to keep it in place. Then, the balloon at the end of the endoscope is deflated and the endoscope is moved through the next part of the small intestine. These steps are repeated many times as the tubes move through the small intestine. The doctor is able to see the inside of the small intestine through the endoscope and use a tool to remove samples of abnormal tissue. Treatment Option Overview Key Points
- There are different types of treatment for patients with small intestine cancer.
- The following types of treatment are used:

- Surgery
- Radiation therapy
- Chemotherapy
- New types of treatment are being tested in clinical trials.
- Immunotherapy
- Radiation therapy with radiosensitizers
- Treatment for small intestine cancer may cause side effects.
- Patients may want to think about taking part in a clinical trial.
- Patients can enter clinical trials before, during, or after starting their cancer treatment.
- Follow-up tests may be needed.
- **Bypass**: Surgery to allow food in the small intestine to go around a tumor that is blocking the intestine but cannot be removed. After the doctor removes all the cancer that can be seen at the time of the surgery, some patients may be given radiation therapy after surgery to kill any cancer cells that are left. Treatment given after the surgery, to lower the risk that the cancer will come back, is called adjuvant therapy.

---

### Arteriovenous malformations of the gastrointestinal tract… [^116e6g9a]. JAMA Network (2025). Excellent credibility.

- During an eight-year period, 17 patients ranging in age from 7 months to 81 years were found to have arteriovenous malformations of the gastrointestinal tract complicated by major hemorrhage. After review of these cases, a clinical classification of AVMs was developed, based on angiographic characteristics, localization, age of the patient, and family history. Type 1 AVMs were solitary, localized lesions within the right side of the colon. They occurred in seven patients 55 years of age or older. None were palpable or visible at operation. Type 2 AVMs occurred in seven patients. They were larger and occasionally visible, most commonly in the small intestine, and probably of congenital origin. Symptoms all began before 50 years of age. Type 3 AVMs were punctate angiomas causing gastrointestinal hemorrhage. They occurred in three patients with the classical findings of hereditary hemorrhagic telangiectasia.

The diagnosis of most AVMs can be determined preoperatively only by selective angiographic studies. Moore JD, Thompson NW, Appelman HD, Foley D. Arteriovenous Malformations of the Gastrointestinal Tract. Arch Surg. 1976; 111: 381–389.

---

### Arteriovenous malformation of the intestine… [^111Xzhqk]. JAMA Network (2025). Excellent credibility.

Acute, intermittent bleeding from an ulcerating arteriovenous malformation of the intestine occurred in three cases. Each lesion was diagnosed by selective mesenteric arteriography and was resected successfully. The report illustrates the limitations of a conventional diagnostic approach in such cases, supports the use of arteriography, and demonstrates the futility of operations other than accurate resection of the bleeding lesion. Cooperman AM, Kelly KA, Bernatz PE, Huizenga KA. Arteriovenous Malformation of the Intestine: An Uncommon Cause of Gastrointestinal Bleeding. Arch Surg. 1972; 104: 284–287.